CURRICULUM VITAE

BURHAN FERHANOGLU, MD.
Professor of Medicine
University of Koc
Department of Internal Medicine
Division of Hematology

EDUCATION

1972 Vefa High School, Istanbul
1978 University of Istanbul Medical School
1978-1982 Istanbul University, Medical School, Department of Internal Medicine, Resident
1982-1984 Military work at Bursa Military Hospital, Department of Internal Medicine
1984-1986 Corum State Hospital, Department of Internal Medicine
1986-1988 Cerrahpasa Medical School, Department of Internal Medicine, Hematology Fellow
1988-1990 Associate professor of Hematology, Cerrahpasa Medical School
1990-1991 University of Texas, Health Science Center, Department of Hematology, Research Fellow, Basic Science Research
1991-1992 Cerrahpasa Medical School, Associate Professor
1992-1993 Fred Hutchinson Cancer Center, Bone Marrow Transplantation Experience
1993 -1994 Associate professor of Cerrahpasa Medical School
1994-2012 Professor of Hematology, Cerrahpasa Medical school
1998- …. V.K.V. American Hospital, Chair of Department of Hematology
2012- … Koc University School of Medicine, Department of Hematology

Awards

1.Çetiner M, Sucak G, Aydın F, Birtaş E, Yozgatlıgil C, Kalaça S, Akı Z, Kalaycıoğlu- Beşışık S, Ferhanoğlu B, Gülbaş Z, Uzay A, Kaygusuz I, Fıratlı- Tuğlular T, Bayık M; “Evaluation of Life Quality in Hematopoietic Stem Cell Transplantation Patients” (Hematopoyetik Kök Hücre Nakli Yapılan Hastalarda Yaşam Kalitesinin Değerlendirilmesi) “Clinical Hematology” award in Turkish Society of Hematology 33rd National Hematology Congress, Ankara, October 16-19, 2007.

2. Demirsoy ET, Ar MC, Öngören Ş, Üre Ü, Başlar Z, Ferhanoğlu B, Aydın Y, Tüzüner N, Ülkü B, Aktuğlu G, Soysal T; “Prognostic Significance of Serum Vascular Endothelial Growth Factor in Chronic Lymphocytic Leukemia” (Kronik Lenfositik Lösemide Serum Vasküler Endotelyal Büyüme Faktörü Düzeyinin Prognoz Değeri) “Schering Lymphoproliferative Disorders” second rank award in Turkish Society of Hematology 32nd National Hematology Congress, Antalya, 2006.

3. Özbalak M, Yürüyen M, Tüzüner N, Ar MC, Güner Şİ, Çetin G, Öngören Ş, Üre Ü, Başlar Z, Soysal T, Aydın Y, Ülkü B, Demir G, Saçlı FS, Ferhanoğlu B; ““Response rates of germinal center and non-germinal center subtypes of DLBCL to R-CHOP chemotherapy in newly diagnosed diffuse large B cell lymphoma evaluated by immunohistochemistry” (Yeni Tanı Almış Diffüz Büyük B Hücreli Lenfomada İmmünhistokimya Aracılığıyla Değerlendirilen Doku Microarray Yöntemi ile Germinal Merkez ve Non-Germinal Merkez Tiplerinin R-Chop Kemoterapisine Yanıtları) “Roche Non-Hodgkin Lymphoma” award. (Turkish Society of Hematology Roche Industry Award) in Turkish Society of Hematology 32nd National Hematology Congress, Antalya, 2006.

4. Ar MC, Sırma S, Hatırnaz Ö, Öngören Ş, Üre Ü, Başlar Z, Aydın Y, Ferhanoğlu B, Özbek U; “Re-evaluation of Minimal Residual Disease by PCR IG/ TCR and Follow-up of Minimal Residual Disease by Detection of Translocation in patients with Acute Lymphoblastic Leukemia: Preliminary Results” (Erişkin Akut Lenfoblastik Lösemili Hastalarda Minimal Rezidüel Hastalığın PCR IG/ TCR Yeniden Yapılanması ve Translokasyon ile Tesbiti ve İzlenmesi: Ön Sonuçlar) “TSH Clinical Laboratory Hematology” award in Turkish Society of Hematology 30th National Hematology Congress, İstanbul, 2003.
REFEREEING in

1. Journal of Istanbul Faculty of Medicine
2. Journal of Osmangazi Faculty of Medicine
3. Journal of Cukurova Faculty of Medicine
4. Turkish Journal of Hematology
5. Journal of Clinical Evolution

MEMBERSHIP of SCIENTIFIC SOCIETIES

1. Turkish Society of Hematology
2. International Society of Hematology
3. American Society of Hematology
4. European Bone Marrow Transplantation Society
5. European Hematology Association

PUBLICATIONS

Translation Editor of

1. Armitage JO, Atlas of Clinical Hematology, Lippncott Williams & Wilkins, ACT Medikal İletişim, 2006. (İlk Basım 2004)
2. Kern W. F., PDQ Hematology, BC Decker Inc. , İstanbul Medikal Yayıncılık, 2005 (İlk Basım 2002)

Book Sections

1. Ed. Teoman Soysal, Burhan Ferhanoğlu, Turkish Society of Hematology, HematoLog (Lymphoma), 2013.
2. Burhan Ferhanoğlu, “Anemia: Definition-Classification, Hematology Course Book” (Anemiler: Tanım-Sınıflama, Hematoloji Ders Kitabı) Üniversite Yayın No: 4774, Cerrahpaşa Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5, sayfa: 21-26, 2008.
3. Teoman Soysal, Burhan Ferhanoğlu, “Hematopoietic Stem Cell Transplantation, Hematology Course Book” (Hematopoetik Kök Hücre Nakli, Hematoloji Ders Kitabı) Üniversite Yayın No: 4774, Cerrahpaşa Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5, sayfa: 207-217, 2008.
4. Burhan Ferhanoğlu, “Mechanism of Hemostasis, Hematology Course Book” (Hemostaz Mekanizması, Hematoloji Ders Kitabı), Üniversite Yayın No: 4774, Cerrahpaşa Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5, sayfa: 219- 227, 2008.
5. Burhan Ferhanoğlu, “Trombphilia, Hematology Course Book” (Trombofili, Hematoloji Ders Kitabı). Üniversite Yayın No: 4774, Cerrahpaşa Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5, sayfa: 251-260, 2008.
6. Burhan Ferhanoğlu, “Anticoagulation Treatment, Hematology Course Book” (Antikoagülan Tedavi, Hematoloji Ders Kitabı), Üniversite Yayın No: 4774, Cerrahpaşa Tıp Fak. Yayın No: 269, ISBN: 978-975-404-815-5, sayfa: 261-264, 2008.
7. Burhan Ferhanoğlu, “Mechanism of Hemostasis, Tendency to Bleeding and Thrombosis” (Hemostaz Mekanizması, Kanama ve Tromboza Eğilim), Editors: Burhan Ferhanoğlu, Zafer Başlar, Tiraje Celkan, Cerrahpaşa Tıp Fak. Yayın No: 36, ISBN: 975-8371-47-9, sayfa: 9-16, Kasım 2003.
8. Burhan Ferhanoğlu, “Trombophilia: Ways to Diagnosis, Tendency to Bleeding and Thrombosis” (Trombofili: Tanıda İzlenecek Yol, Kanama ve Tromboza Eğilim), Editörler: Burhan Ferhanoğlu, Zafer Başlar, Tiraje Celkan, Cerrahpaşa Tıp Fak. Yayın No: 36, ISBN: 975-8371-47-9, sayfa: 143-158, Kasım 2003.

Papers Published in International Journals

1. Yemisen M, Balkan, II, Salihoglu A, Eskazan AE, Mete B, Ar MC, Ongoren S, Baslar Z, Ozaras R, Saltoglu N, Mert A, Ferhanoglu B, Ozturk R, Tabak F, Soysal T. The Changing Epidemiology of Blood Stream Infections and Resistance in Haematopoietic Stem Cell Transplantation Recipients. Turk J Haematol. 2015.
2. Salihoglu A, Elverdi T, Karadogan I, Paydas S, Ozdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin Z, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Ferhanoglu B. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Ann Hematol. 2015; 94(3): 415-20.
3. Ozturk E, Ozbalak M, Berk S, Erdogan I, Avsar E, Dolgun A, Cetiner M, Mandel NM, Yalniz FF, Elverdi T, Salihoglu A, Eskazan AE, Ar MC, Ongoren S, Baslar Z, Aydin Y, Soysal T, Ferhanoglu B. Comparison of International Prognostic Index and NCCN-IPI in 324 patients with de novo diffuse large B-cell lymphoma: a multi-center retrospective analysis. Leuk Lymphoma. 2015: 1-4.
4. Offner F, Samoilova O, Osmanov E, Eom HS, Topp MS, Raposo J, Pavlov V, Ricci D, Chaturvedi S, Zhu E, van de Velde H, Enny C, Rizo A, Ferhanoglu B. Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL. Blood. 2015; 126(16): 1893-901.
5. Islak Mutcali S, Saltoglu N, Balkan, II, Ozaras R, Yemisen M, Mete B, Tabak F, Mert A, Ozturk R, Ongoren S, Baslar Z, Aydin Y, Ferhanoglu B, Soysal T. Early Changes of Mannose Binding Lectin, H-ficolin and Procalcitonin in Patients With Febrile Neutropenia: A Prospective, Observational Study. Turk J Haematol. 2015.
6. Demirel A, Tabak F, Ar MC, Mete B, Ongoren S, Yemisen M, Ozaras R, Eskazan AE, Baslar Z, Mert A, Soysal T, Ferhanoglu B, Aydin Y, Ozturk R. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode. Turk J Haematol. 2015.
7. Aydin SO, Eskazan AE, Berk S, Erdogan I, Yalniz FF, Elverdi T, Salihoglu A, Ar MC, Baslar Z, Soysal T, Ferhanoglu B, Tuzuner N, Aydin Y. Retrospective Evaluation of 83 Patients with Hairy Cell Leukemia Treated with 3 Different Treatment Modalities in the Last Two Decades: A Single Center Experience. Haematologica. 2015; 100: 424-5.
8. Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B. Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin. Int J Infect Dis. 2014; 19: 53-8.
9. Soysal T, Salihoglu A, Esatoglu SN, Gulturk E, Eskazan AE, Hatemi G, Hatemi I, Aydin SO, Erzin YZ, Baslar Z, Tuzuner N, Ferhanoglu B, Celik AF. Bone marrow transplantation for Behcet’s disease: a case report and systematic review of the literature. Rheumatology. 2014; 53(6): 1136-41.
10. Ferhanoglu B, Salihoglu A, Elverdi T, Karadogan I, Ozdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin A, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Paydas S. Brentuximab Vedotin for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey. Haematologica. 2014; 99: 675-6.
11. Eskazan AE, Eyice D, Kurt EA, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Ongoren Aydin S, Baslar Z, Ferhanoglu B, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion. Leuk Res. 2014; 38(7): 781-7.
12. Cetin G, Eskazan AE, Ar MC, Aydin SO, Ferhanoglu B, Soysal T, Baslar Z, Aydin Y. Bone-Specific Alkaline Phosphatase Levels among Patients with Multiple Myeloma Receiving Various Therapy Options. Turk J Haematol. 2014; 31(4): 374-80.
13. Berk S, Ozgur N, Yalniz FF, Elverdi T, Salihoglu A, Eskazan AE, Ar MC, Baslar Z, Soysal T, Ferhanoglu B, Tuzuner N, Aydin Y, Aydin SO. Primary Gastointestinal Non-Hodgkin’s Lymphoma: Retrospective Evaluation of 50 Patients. Haematologica. 2014; 99: 694-.
14. Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P, Warden J, Stevens L, Pocock CF, Miall F, Cunningham D, Davies J, Jack A, Stephens R, Walewski J, Ferhanoglu B, Bradstock K, Linch DC. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol. 2014; 15(4): 424-35.
15. Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Cetiner M, Ferhanoglu B. Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature. Transfusion. 2013; 53(7): 1586-93.
16. Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B. Diagnostic Contribution of F-18 FDG-PET/CT on the Management of FUO. Eur J Nucl Med Mol I. 2013; 40: S138-S.
17. Salihoglu A, Ozbalak M, Keskin D, Tecimer T, Soysal T, Ferhanoglu B. An unusual presentation of a chronic lymphocytic leukemia patient with 17p deletion after reduced-intensity transplantation: Richter syndrome and concomitant graft-versus-host disease–case report. Transplant Proc. 2013; 45(7): 2845-8.
18. Salihoglu A, Hatemi I, Senel TE, Aki H, Ferhanoglu B. Massive gastrointestinal bleeding during the course of chronic myelomonocytic leukemia. J Gastrointestin Liver Dis. 2013; 22(1): 7.
19. Sahin F, Saydam G, Comert M, Uz B, Yavuz AS, Turan E, Yonal I, Atay H, Keltikli E, Turgut M, Pehlivan M, Akay MO, Gurkan E, Paydas S, Kahraman S, Demirkan F, Kirkizlar O, Akpinar S, Pamuk GE, Demir M, Ozbas HM, Sonmez M, Gulturk M, Salihoglu A, Eskazan AE, Ar C, Haydaroglu Sahin H, Ongoren S, Baslar Z, Aydin Y, Yenere MN, Tuzuner N, Ferhanoglu B, Haznedaroglu IC, Ilhan O, Soysal T. Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients. Turk J Haematol. 2013; 30(4): 351-8.
20. Ozbalak M, Tokatli I, Ozdemirli M, Tecimer T, Ar MC, Ornek S, Koroglu A, Laleli Y, Ferhanoglu B. Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(-) EBV(-) HHV8(+) patient. Eur J Haematol. 2013; 91(5): 467-9.
21. Ozbalak M, Ar MC, Tuzuner N, Salihoglu A, Eskazan AE, Ongoren Aydin S, Baslar Z, Soysal T, Aydin Y, Barak Dolgun A, Ergonul O, Ferhanoglu B. Detailed analysis of diffuse large B cell lymphoma patients: a single-center, retrospective study. ISRN Hematol. 2013; 2013: 908191.
22. Erbilgin Y, Eskazan AE, Ng OH, Salihoglu A, Elverdi T, Firtina S, Tatonyan SC, Aydin SO, Ar MC, Baslar Z, Sayitoglu M, Ferhanoglu AB, Aydin Y, Ozbek U, Soysal T. Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance. Blood. 2013; 122(21).
23. Aki H, Uzunaslan D, Saygin C, Demir H, Salihoglu A, Ferhanoglu B, Tuzuner N. Clinicopathologic features of primary thyroid lymphomas: A single center experience. Virchows Arch. 2013; 463(2): 151-.
24. Selcukbiricik F, Tural D, Elicin O, Berk S, Ozguroglu M, Bese N, Ferhanoglu B. Primary gastric lymphoma: conservative treatment modality is not inferior to surgery for early-stage disease. ISRN Oncol. 2012; 2012: 951816.
25. Ferhanoglu B, Ozbalak M. Diffüz Büyük B Hücreli Lenfoma (Article published in Turkish, Title: Diffuse Large B Cell Lymphoma). HematoLog-Special Issue on Lymphoma. 2013; 3(2): 355-81.
26. Ferhanoglu B, Ozbalak M. Primer Merkezi Sinir Sistemi Lenfomaları (Article published in Turkish, Title: Primary Central Nervous System Lymphomas). HematoLog-Special Issue on Lymphoma. 2013; 3(2): 382-94.
27. Ozturk M, Ozaydin S, Oyan B, Ozbalak M, Arpaci F, Paydas S, Ataergin S, Ferhanoglu B, Kocak N, Gurkan E, Ozet A, Barista I. The comparison of up-front autologous peripheral stem cell transplantation in first remission and long-lasting intensive chemotherapy protocols in highly aggressive non-Hodgkin’s lymphomas: Results of a retrospective analysis. J Clin Oncol. 2012; 30(15).
28. Ozbalak M, Cetiner M, Bekoz H, Atesoglu EB, Ar C, Salihoglu A, Tuzuner N, Ferhanoglu B. Azacitidine has limited activity in ‘real life’ patients with MDS and AML: a single centre experience. Hematol Oncol. 2012; 30(2): 76-81.
29. Ari MC, Buyuktas D, Eskazan AE, Ongoren Aydin S, Tanrikulu E, Baslar Z, Buyru AN, Ferhanoglu B, Aydin Y, Tuzuner N, Soysal T. The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Turk J Haematol. 2012; 29(3): 242-7.
30. Offner F, Ferhanoglu B, Reeves JA, Eom HS, Doner K, Raposo J, Flinn IW, Suh C, Chowhan NM, Prasad S, Kussick SJ, Mulligan G, Rizo A, Leonard JP. Phase 2 Studies of Immunochemotherapy +/- Bortezomib (Vc) in Newly Diagnosed Non-Germinal Center B-Cell-Like (Gcb) Dlbcl: Rapid Prospective Identification of Non-Gcb Patients (Pts). Ann Oncol. 2011; 22: 225-.
31. Leonard J, Reeves J, Ferhanoglu B, Doner KT, Eom H, Flinn IW, Raposo J, Chowhan NM, Suh C, Noga S, Tumyan G, Aung S, Hajdenberg J, Ulrich BK, Pendergrass KB, Mulligan G, Rizo A, Kussick S, Offner F. PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification. J Clin Oncol. 2011; 29(15).
32. Eskazan AE, Tatonyan SC, Salihoglu A, Gulturk E, Ar MC, Aydin SO, Baslar Z, Ferhanoglu AB, Tuzuner N, Aydin Y, Ozbek U, Soysal T. Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia. Blood. 2011; 118(21): 736-.
33. Eskazan AE, Soysal T, Ongoren S, Gulturk E, Ferhanoglu B, Aydin Y. Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy. Haematologica. 2011; 96(3): e15; author reply e6-7.
34. Eskazan AE, Soysal T, Erbilgin Y, Ozbek U, Ferhanoglu B. Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: is that true for all the patients? Leuk Res. 2011; 35(9): e145-6.
35. Eskazan AE, Ongoren S, Ar MC, Soysal T, Ferhanoglu B, Aki H, Aydin Y. Essential thrombocythemia and multiple myeloma: two rare diseases in one patient. Clin Lymphoma Myeloma Leuk. 2011; 11(5): 442-5.
36. Eskazan AE, Akmurad H, Ongoren S, Ozer O, Ferhanoglu B. Primary gastrointestinal diffuse large B cell lymphoma presenting with cold agglutinin disease. Case Rep Gastroenterol. 2011; 5(2): 262-6.
37. Arslan F, Tabak F, Avsar E, Midilli K, Mert A, Ozaras R, Soysal T, Ozturk R, Ferhanoglu B. Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient. J Neurovirol. 2010; 16(2): 174-8.
38. Ardeshna KM, Qian WD, Smith P, Warden J, Stevens L, Pocock CFE, Miall F, Cunningham D, Davies J, Walewski J, Ferhanoglu AB, Bradstock K, Linch DC. An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicullar Lymphoma (Grades 1, 2 and 3a). A Preliminary Analysis. Blood. 2010; 116(21): 5-.
39. Ure U, Ar MC, Baslar Z, Soysal T, Ongoren S, Gulseven M, Aydin Y, Ulku B, Tuzuner N, Ferhanoglu B. The Effect of ZAP-70 Expression on Disease Progression in Early-Stage (Binet A) B-CLL Patients. Trak Univ Tip Fak De. 2009; 26(4): 317-21.
40. Tarkan-Arguden Y, Ar MC, Yilmaz S, Ongoren S, Kuru D, Ure U, Cirakoglu A, Eskazan AE, Guven GS, Cetin G, Purisa S, Baslar Z, Deviren A, Aydin Y, Hacihanefioglu S, Ferhanoglu B, Tuzuner N, Ulku B, Soysal T. Cytogenetic Clonal Evolution in Patients with Chronic Myeloid Leukemia. Biotechnol Biotec Eq. 2009; 23(4): 1515-20.
41. Saydam G, Haznedaroglu IC, Temiz Y, Soysal T, Sucak G, Tombuloglu M, Ozdogu H, Yavuz S, Altintas A, Ozet G, Gulbas Z, Ferhanoglu B, Ilhan O. Retrospective Evaluation of Patients Treated with Dasatinib for Philadelphia Positive Leukemias: Turkish Experience of 16 Months. Uhod-Uluslar Hematol. 2009; 19(4): 195-204.
42. Ozer O, Eskazan AE, Ar MC, Bekoz H, Tabak F, Ongen G, Ferhanoglu B. Sarcoidosis mimicking lymphoma on positron emission tomography-computed tomography in two patients treated for lymphoma: two case reports. J Med Case Rep. 2009; 3: 7306.
43. Ongoren S, Tarkan-Arguden Y, Ar MC, Yilmaz S, Ure U, Kuru D, Eskazan AE, Guven GS, Cetin G, Cirakoglu A, Baslar Z, Deviren A, Aydin Y, Hacihanefioglu S, Ferhanoglu B, Tuzuner N, Ulku B, Soysal T. Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center. Turk Klin Tip Bilim. 2009; 29(2): 321-30.
44. Ar MC, Ozbalak M, Tuzuner N, Bekoz H, Ozer O, Ugurlu K, Tabak F, Ferhanoglu B. Severe bone marrow failure due to valganciclovir overdose after renal transplantation from cadaveric donors: four consecutive cases. Transplant Proc. 2009; 41(5): 1648-53.
45. Igdem S, Okkan S, Unalan B, Igdem A, Ferhanoglu B. Cervical cancer coexisting with small lymphocytic lymphoma detected during positron emission tomography/computed tomography simulation: a case report. Eur J Gynaecol Oncol. 2008; 29(4): 405-7.
46. Erdogan EB, Guner SI, Sonmezoglu K, Ferhanoglu B, Halac M, Uslu I. Can post-treatment PET/CT scanning after first-line chemotherapy predict the prognosis in patients with Hodgkin disease and high-grade nonHodgkin lymphoma? Eur J Nucl Med Mol I. 2008; 35: S221-S.
47. Ure UB, Ar MC, Salihoglu A, Guner SI, Baran A, Oguz O, Ferhanoglu B. Alemtuzumab in Sezary syndrome: efficient but not innocent. Eur J Dermatol. 2007; 17(6): 525-9.
48. Üre Ü, Özer Ö, Beköz H, Tüzüner N, B F. İmages 96: Hodgkin Lymphoma Presenting as a Palpable Scalp Mass. Bloodmed. 2007.
49. Soer M, Ozbalak M, Senocak M, Soysal T, Ferhanoglu B, Molinas N, Tuzuner N. Prognostic significance of micro vessel density in diffuse large B cell lymphomas. Virchows Arch. 2007; 451(2): 357-8.
50. Sili U, Yilmaz M, Ferhanoglu B, Mert A. Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole. Clin Infect Dis. 2007; 45(7): 897-8.
51. Ozer O, Eskazan E, Bekoz H, Peker K, Yuksel S, Altiok E, Ferhanoglu B. A case of V617F(+) myelodysplastic/myeloproliferative disorder. Virchows Arch. 2007; 451(2): 434-.
52. Hatirnaz O, Ure U, Ar C, Akyerli C, Soysal T, Ferhanoglu B, Ozcelik T, Ozbek U. The SOCS-1 gene methylation in chronic myeloid leukemia patients. Am J Hematol. 2007; 82(8): 729-30.
53. Hatirnaz O, Ekmekci CG, Ar C, Ure U, Soysal T, Ferhanoglu B, Ozbek U. Detection of SOCS-1 (suppressor of cytokine signaling-1) methylation in CML (chronic myeloid leukemia) patients. Febs J. 2006; 273: 322-.
54. Pamuk ON, Pamuk GE, Soysal T, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul. South Med J. 2004; 97(3): 240-5.
55. Aki H, Tuzuner N, Ongoren S, Baslar Z, Soysal T, Ferhanoglu B, Sahinler I, Aydin Y, Ulku B, Aktuglu G. T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma. Leuk Res. 2004; 28(3): 229-36.
56. Gurses N, Kalayoglu-Besisik S, Sargin D, Ferhanoglu B, Anak S, Soysal T, Baslar Z, Ongoren S, Bilgen H, Gedykoglu G, Aydin M, Abacy N, Gul A, Ozbek U. Interleukin-6 gene polymorphisms associate with acute graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation. Bone Marrow Transpl. 2003; 31: S129-S.
57. Ferhanoglu B, Ongoren S, Ar CM, Uzel B, Forta H, Necioglu D. Intrathecal methotrexate-induced acute cerebellar syndrome. Ann Hematol. 2003; 82(4): 241-3.
58. Akan H, Uzun O, Akova M, Senol E, Ozkalemkas F, Ferhanoglu B, Dincer S, Korten V. FUNGOBASE: An epidemiological study to determine the trends in antifungal treatment in Turkey. Trends in Medical Mycology. 2003: 43-7.
59. Tiryakioglu O, Kadioglu P, Ongoren S, Acbay O, Ferhanoglu B, Gundoglu S, Korugan U. An unusual cause of hypercalcemia in polycythemia vera: parathyroid adenoma. Acta Med Okayama. 2002; 56(3): 167-70.
60. Pamuk GE, Pamuk ON, Soysal T, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. An overview of young CLL patients: a single-centre experience from Turkey. Haematologia. 2002; 31(4): 303-11.
61. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Ann Hematol. 2002; 81(8): 436-40.
62. Ozbek U, Gurses N, Kalayoglu-Besisik S, Aydin M, Bilgen H, Ongoren S, Yalman N, Anak S, Baslar Z, Soysal T, Ferhanoglu B, Gedikoglu G, Sargin D. The value of TNF-alpha and IL-10 gene polymorphisms in the incidence and severity of graft-versus-host disease. Bone Marrow Transpl. 2002; 29: S198-S.
63. Ozbek U, Gurses N, Kalayoglu-Besisik S, Aydin M, Bilgen H, Ongoren S, Yalman N, Abaci N, Anak S, Baslar Z, Soysal T, Gul A, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Gedikoglu G, Sargin D. Cytokine gene polymorphism in patients with graft-versus-host disease after HLA-matched bone marrow transplantion. Blood. 2001; 98(11): 361b-b.
64. Ferhanoglu AB, Acicbe O, Ongoren S, Tabak F, Baslar Z, Ozturk R, Soysal T, Mert A, Yilmaz M, Murtezaoglu A, Aydin Y, Ulku B, Aktuglu G, Aktuglu Y. Profile of microorganisms isolated from febrile neutropenic patients. Blood. 2001; 98(11): 26b-b.
65. Erman M, Akova M, Akan H, Korten V, Ferhanoglu B, Koksal I, Cetinkaya Y, Uzun O, Unal S. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: a prospective, randomized, multicenter study. Scand J Infect Dis. 2001; 33(11): 827-31.
66. Soysal T, Pamuk ON, Pamuk GE, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. An overview of young CLL patients. Blood. 2000; 96(11): 294b-b.
67. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y, UIku B, Aktuglu G, Akman N. A single center experience with 321 ITP patients. Blood. 2000; 96(11): 68b-9b.
68. Giles FJ, Shan J, Advani SH, Akan H, Aydogdu I, Aziz Z, Azim HA, Bapsy PP, Buyukkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, Khalid HM, Intragumtornchai T, Kim SW, Kim SY, Koc H, Kumar L, Kumar R, Lei KI, Lekhakula A, Muthalib A, Patel M, Poovalingam VP, Prayoonwiwat W, Rana F, Reksodiputro AH, Ruff P, Sagar TG, Schwarer AP, Song HS, Suh CW, Suharti C, Supindiman I, Tee GY, Thamprasit T, Villalon AH, Wickham NR, Wong JE, Yalcin A, Jootar S. A prospective randomized study of Chop versus Chop plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin’s lymphoma: the International Oncology Study Group NHL1 Study. Leuk Lymphoma. 2000; 40(1-2): 95-103.
69. Demircioglu M, Ongoren S, Uzel B, Karadogan I, Aky H, Tuzuner N, Undar L, Ferhanoglu B. Comparison of flow cytometry with other methods in diagnosis of PNH. Blood. 2000; 96(11): 10b-b.
70. Budak T, Besisik S, Akan H, Baslar Z, Ratip S, Koc H, Ferhanoglu B, Bayik M, Tangun Y. The prevalence of tuberculosis (TBC) in adult allogeneic stem cell transplant recipients in Turkey. Bone Marrow Transpl. 1999; 23: S123-S.
71. Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aktuglu G, Ulkii B. Extramedullary relapse after allogeneic stem cell transplantation. Bone Marrow Transpl. 1999; 23: S2-S.
72. Aydingoz IE, Ferhanoglu B, Guney O. Does tissue iron status have a role in female alopecia? J Eur Acad Dermatol Venereol. 1999; 13(1): 65-7.
73. Ulutin ON, Ulutin ŞB, Çizmeci G, T U, B F. Some Clinical, Pharmacological Observations of the Effect of Defibrotide in Human. Acta Pharmaceutica Turcica. 1998; (30): 57-62.
74. Soysal T, Baslar Z, Ferhanoglu B, Akman N. Donor leukocyte infusions for acute myeloid leukemia relapsing after stem cell transplantation. Acta Haematol. 1998; 99(1): 49-51.
75. Baslar Z, Soysal T, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B. Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient. Bone Marrow Transpl. 1998; 22(4): 404-5.
76. Ozen S, Ferhanoglu B, Senocak M, Tuzuner N. Idiopathic myelofibrosis (agnogenic myeloid metaplasia): clinicopathological analysis of 32 patients. Leuk Res. 1997; 21(2): 125-31.
77. Ozbek U, Vural B, Kalayoglu S, Soysal T, Bilgen H, Yavuz S, Anak S, Sargin D, Gedikoglu G, Ferhanoglu B, Akoglu T, Tangun Y, Ozcelik T. Evaluation of chimerism with DNA polymorphisms in bone marrow transplantation. Turk J Pediatr. 1997; 39(3): 303-11.
78. Ferhanoglu B, Erzin Y, Baslar Z, Tuzuner HA. Secondary amyloidosis in the course of idiopathic myelofibrosis. Leuk Res. 1997; 21(9): 897-8.
79. Baslar Z, Soysal T, Hanci M, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B. Successful outcome of aspergillus brain abscess in a patient who underwent bone marrow transplantation for aplastic anemia. Haematologia. 1997; 28(4): 265-71.
80. Başlar Z, Tüfekçi IB, Soysal T, Ferhanoğlu B, Aydın Y, Aktuğlu G, Akman N , B Ü. Neutropenic Enterocolitis In Acute Leukemia. Turkish Journal Of Haematology. 1997; (14): 109-12.
81. Ulutin ON, Balkuv-Ulutin S, Bezer-Goker B, Cizmeci G, Ferhanoglu B, Ozsoy Y, Ugur MS, Ulutin T, Yaman A, Yardimci T. Effect of defibrotide on platelet function. Semin Thromb Hemost. 1996; 22 Suppl 1: 21-4.
82. Sayman HB, Sonmezoglu K, Altiok E, Devranoglu G, Ferhanoglu B. Unexpected bone marrow uptake of thallium-201 in nonsecretory myeloma. J Nucl Med. 1995; 36(2): 250-1.
83. Soysal T, Ferhanoglu B, Bilir M, Akman N. Oculomotor nerve palsy associated with vincristine treatment. Acta Haematol. 1993; 90(4): 209-10.
84. Ertugrul H, Aydemir A, Ferhanoglu B, Oğuz O, Akçakaya N, Tozakı S, Avanoglu Y, Y G. Hyper IgE Syndrome Amiloidosis and Developmental Defect. Turkish Journal of Medical and Biological Research. 1992; (3): 305-9.
85. Wu KK, Sanduja R, Tsai AL, Ferhanoglu B, Loose-Mitchell DS. Aspirin inhibits interleukin 1-induced prostaglandin H synthase expression in cultured endothelial cells. Proc Natl Acad Sci U S A. 1991; 88(6): 2384-7.
86. Ulutin ON, Ulutin SB, Ugur MS, Ulutin T, Erbengi T, Ferhanoglu B, T Y. Defibrotide and its Effects on Platelet Function. In: Thrombosis and Haemorrhagic Disorders. In: Vinazzer HSaH, ed. Schimmitt and Meyer GmBH Winzburg; 1989. p. 426-28.
87. Ulutin ON, Ulutin SB, Çizmeci G, T U, Ferhanoglu B. Some Clinical, Pharmacological Observations of the Effect of Defibrotide in Human. Acta Pharmaceutica Turcica. 1988; (30): 57-62.

International Conference Presentations

1. Ferhanoğlu B, Öztürk E, Berk S, Erdoğan I, Özbalak M, Avşar E, Dolgun A, Çetiner M, Molinas N, Yalnız FF, Elverdi T, Salihoğlu A, Eşkazan AE, Ar MC, Aydın Ş, Başlar Z, Aydın Y, Soysal T COMPARISON OF IPI AND NCCN-IPI IN 324 DE NOVO DLBCL PATIENTS: MULTICENTER RETROSPECTIVE ANALYSIS 13-ICML, 13th International Conference on Malignant Lymphoma, Poster Session, Abstract No:357, Palazzo dei Congressi, Lugano (Switzerland), 17-20 June, 2015
2. Erbilgin Y, Eskazan AE, Hatirnaz Ng O, Salihoglu A, Elverdi T, Firtina S Catal Tatonyan S, Ongoren Aydin S, Ar MC, Baslar Z, Sayitoglu M, Ferhanoglu B, Aydin Y, Ozbek U, Soysal T Next-Generation Sequencing Of The BCR-ABL1 Kinase Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance. 53rd ASH Annual Meeting and Exposition, Oral Session, Abstract No:384, December 7-10, 2013, Louisiana, New Orleans, USA.
3. Offner F, Samoilova O, Osmanov E, Eom H, Topp M, Raposo J, Pavlov V, Ricci D, Zhu E, Velde H.van de, Enny C, Rizo A, Ferhanoglu B. PHASE 2 STUDY OF RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE WITH BORTEZOMIB (VCR-CAP) OR VINCRISTINE (R-CHOP) IN PATIENTS WITH NEWLY DIAGNOSED NON-GERMINAL CENTRE B-CELL-LIKE DIFFUSE LARGE B-CELL LYMPHOMA Special Issue: 12th International Conference on Malignant Lymphoma, Poster Session, Abstract No:214, Palazzo dei Congressi, Lugano, Switzerland, June 19–22, 2013
4. Murat OZBALAK, M. Cem AR, Nükhet TUZUNER, Ayşe SALIHOGLU, A. Emre ESKAZAN, Şeniz Ongoren AYDIN, Zafer BASLAR, Teoman SOYSAL, Yildiz AYDIN, Anıl Barak DOLGUN, Onder ERGONUL & Burhan FERHANOGLU. 2013. Detailed analysis of diffuse large B cell lymphoma patients: A single center, retrospective study reporting on young patients.- Poster Presentation In 4th International Congress of Leukemia-Lymphoma-Myeloma. Istanbul.
5. Murat OZBALAK, Ilyas Tokatlı, Metin Özdemirli, Tulay Tecimer, M. Cem Ar, Serdar Örnek, Aykut Koroglu, Yahya Laleli & Burhan Ferhanoglu. 2013b. IS VALGANCICLOVIR REALLY EFFECTIVE IN PRIMARY EFFUSION LYMPHOMA?: CASE REPORT OF AN HIV(-) EBV(-) HHV8(+) PATIENT. Poster Presentation: In 4th International Congress of Leukemia-Lymphoma-Myeloma. Istanbul, Turkey
6. Cagatay KUNDAK, Murat OZBALAK, Serdar ORNEK, Burhan FERHANOGLU & Yahya Rauf LALELİ. 2013. RECOGNITION OF IMMUNOGLOBULIN D MULTIPLE MYELOMA CASE REPORT AND SHORT REVIEW. Poster Presentation: In 4th International Congress of Leukemia-Lymphoma-Myeloma. Istanbul, Turkey.
7. Ozturk M, Ozaydin S, Oyan B, Ozbalak M, Arpaci F, Paydas S, Ataergin S, Ferhanoglu B, Kocak N, Gurkan E, Ozet A, Barista I; The comparison of up-front autologous peripheral stem cell transplantation in first remission and long-lasting intensive chemotherapy protocols in highly aggressive non-Hodgkin’s lymphomas: Results of a retrospective analysis, ASCO 48th Annual Meeting 2012, June 1–5, 2012, Chicago, Illinois, USA.
8. Leonard J, Reeves J, Ferhanoglu B, Doner KT, Eom H, Flinn IW, Raposo J, Chowhan NM, Suh C, Noga S, Tumyan G, Aung S, Hajdenberg J, Ulrich BK, Pendergrass KB, Mulligan G, Rizo A, Kussick S, Offner F; PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification, ASCO 47th Annual Meeting 2011, June 3–7, 2011, Chicago, Illinois, USA.
9. Ardeshna KM, Smith P, Qian W, Warden J, Stevens L, Pocock CFE, Miall F, Cunningham D, Davies J, Jack A, Walewski J, Ferhanoglu B, Bradstock K and Linch DC; An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicular Lymphoma (Grades 1, 2 and 3a), A Preliminary Analysis., 53rd ASH Annual Meeting and Exposition, Plenary Scientific Session (6th from among 5,493 abstract submissions), December 10-13, 2011, San Diego, CA, USA.
10. Eskazan AE, Tatonyan SC, Salihoglu A, Gulturk E, Ar MC, Ongoren Aydin S, Baslar Z, Ferhanoglu B, Tuzuner N, Aydin Y, Ozbek U, Soysal T : Multidrug Resistance Gene (MDR1) C3435T Polymorphism and Imatinib Response in Patients with Chronic Myeloid Leukemia. 53rd ASH Annual Meeting and Exposition, Poster Session, Abstract No:1692, December 10-13, 2011, San Diego, CA, USA.
11. Ferhanoglu B; Non-Hodgkin lymphoma – Clinical, 16th Congress of EHA: June 9 – 12, 2011, Excel London, United Kingdom.
12. Ferhanoglu B; DLBCL First Line Treatment, 3rd International Congress on Lymphoma- Leukemia- Myeloma (LLM) Congres,Turkish Society of Hematology, 11-14 May 2011, İstanbul, TURKEY.
13. Ferhanoglu B; DLBCL First Line Treatment, 1th International Lymphoma- Leukemia- Myeloma (LLM) Congres,Turkish Society of Hematology, Fethiye, 24- 27 May 2007.
14. Hatırnaz O, Ekmekçi CG, Ar MC, Üre Ü, Soysal T, Ferhanoğlu B, Özbek Ö; Detection of SOCS-1 (Suppressor of Cytokine Signaling-1) Methylation in CML (Chronic Myeloid Leukemia) Patients, Febs Journal; 273: 322-322 pp915 Suppl. 1, Jun 2006.
15. Gürses N, Kalaycıoğlu- Beşışık S, Sargın D, Ferhanoğlu B, Anak S, Soysal T, Başlar Z, Öngören Ş, Bilgen H, Gedikoğlu G, Aydın M, Abacı N, Gül A, Özbek Ü Interleukin-6 Gene Polymorphisms Associate with Acute Graft-versus-Host Disease in HLA-matched Allogeneic Hematopoietic Stem Cell Transplantation. Bone Marrow Transplantation; 31: S129- S129 Suppl. 1, Mar 2003.
16. Özbek Ü, Gürses N, Kalayoğlu- Beşışık S, Aydın M, Bilgen H, Öngören Ş, Yalman N, Anak S, Başlar Z, Soysal T, Ferhanoğlu B, Gedikoğlu G, Sargın D; The Value of TNF-Alfa and IL-10 Gene Polymorphisms in the Incidence and Severity of Graft-versus-Host Disease, Bone Marrow Transplantation; 29: 198- 198 Suppl. 2 Mar 2002.
17. Özbek Ü, Gürses N, Kalayoğlu- Beşışık S, Aydın M, Bilgen H, Öngören Ş, Yalman N, Abacı N, Anak S, Başlar Z, Soysal T, Gül A, Ferhanoğlu B, Aydın Y, Ülkü B, Aktuğlu G, Gedikoğlu G, Sargın D; Cytokine Gene Polymorphisims in Patients with Graft-versus- Host Disease After HLA-matched Bone Marrow Transplantation, Blood; 98 (11): 5216 part 2, Nov 2001.
18. Demircioğlu M, Öngören Ş, Uzel B, Karadoğan I, Akı H, Tüzüner N, Undal L, Ferhanoğlu B; Comparison of Flow Cytometry with Other Methods in Diagnosis of PNH, Blood; 96(11): 3696 Part 2, Nov 2000.
19. Pamuk GE, Pamuk ON, Başlar Z, Öngören Ş, Soysal T, Ferhanoğlu B, Aydın Y, Ülkü B, Aktuğlu G, Akman N; A Single Center Experience with 321 ITP Patients, Blood; 96(11): 3970 Part 2, Nov 2000.
20. Başlar Z, Öngören Ş, Soysal T, Ferhanoğlu B, Aktuğlu G, Ülkü B; Extramedullary Relapse After Allogeneic Stem Cell Transplantation, 25th Annual Meeting of the EBMT and 15th Meeting of the Nurses Group, Hamburg, 21- 25 Mar 1999.
21. Başlar Z, Öngören Ş, Soysal T, Ferhanoğlu B, Aktuğlu G, Ülkü B; Extrameullary Relapse After Allogeneic Stem Cell Transplantation, Bone Marrow Transplantation; 23: 4 Suppl., Mar 1999.
22. Budak T, Beşışık S, Akan H, Başlar Z, Ratip S, Koç H, Ferhanoğlu B, Bayık M, Taygun Y; The Prevalance of Tuberculosis (TBC) in Adult Allogenic Stem Cell Transplant Recipients in Turkey, Bone Marrow Transplantation; 23: 404 Suppl., Mar 1999.
23. Aydın F, Oğuz FS, Kalayoğlu S, Başlar Z, Gürtekin M, Soysal T, Sargın D; Ferhanoğlu B, Çarin M; The Relation Between HLA Antigens and GVHD in Turkish Patients Transplanted with HLA Identical Hematopoietic Stem Cell, 23rd Annual Meeting of the EBMT and 13th Meeting of the Nurses Group, Aix- Le Bains, 23- 27 Mar 1997.
24. Kalayoğlu S, Soysal T, Başlar Z, Yenerer MN, Yavuz AS, Sargın D, Ferhanoğlu B, Atamer T, Akman N, Tangün Y; Donor Leukocyte Infusions for Acute Myeloid Leukemia (AML) Relapsing After Stem Cell Transplantation ( SCT ), 23rd Annual Meeting of the EBMT and 13th Meeting of the Nurses Group, Aix- Le Bains, 23- 27 Mar 1997.
25. Başlar Z, Tüfekçi BI, Soysal T , Ferhanoğlu B, Aydın Y, Aktuğlu G, Akman N, Ülkü B; Neutropenic Enterocolitis In Acute Leukemia, Turkish Journal of Haematology , 14: 109- 112, 1997.
26. Çungurlu A, Başlar Z, Demir G, Özgüroğlu M, Soysal T, Molinas N, Ferhanoğlu B, Büyükünal E, Aydın Y, Serdengeçti S, Aktuğlu G, Akman N, Ülkü B, Berkarda B; Treatment Induced Second Neoplasms in Hodgkin’s Disease. 10th Meditterranean Congress of Chemotherapy, Antalya, 20- 25 Oct 1996.
27. Başlar Z, Aşlamacı M, Zülfikar B, Soysal T, Ferhanoğlu B, Aydın Y, Ülkü B, Akman N, Aktuğlu G; Incidence of HBV, HCV, HIV Markers in Hemophilia, XIIIth Meeting of The International Society of Hematology ( European- African Division), Istanbul, Turkey, 3- 8 Sep 1995.
28. Koç H, Akman N, Tunalı A, Ferhanoğlu B, Yücel I, İlhan O, Beksaç M, Aydın Y, Akan H, Özcan M, Konuk N, Aktuğlu G, Gürman G, Ülkü B; Interferon Alfa-2b Compared to Interferon Alfa-2b Plus Chemotherapy for Remission Maintenance in Multiple Myeloma: A Multicenter Study, XIIIth Meeting of the International Society of Hematology, Istanbul, Turkey, 3- 8 Sep 1995. Abs.No 915
29. Eralp Y, Ferhanoğlu B, Demir M, Hız M, Tüzüner N, Akman N,Türemen E; Primary Lymphoma of Bone, XIIIth Meeting of The International Society of Hematology, Istanbul, Turkey, 3- 8 Sep 1995. Abs. No 904.
30. Gürel N, Doğusoy G, Ferhanoğlu B, Ülkü B, Molinas N, Tüzüner N; Immunophenotyping and DNA Flow Cytometric Analysis of Non_Hodgkin’s Lymphoma, XIIIth Meeting of The International Society of Hematology, Istanbul, Turkey, 3- 8 Sep 1995. Abs. No 905.
31. Özen S, Ferhanoğlu B, Doğusoy G and Tüzüner N; Idiopatic Myelofibrosis, Clinicopatologic Analysis of 32 Patients, XIIIth Meeting of The International Society of Hematology, Istanbul, Turkey, 3- 8 Sep 1995. Abs. No911.
32. Başlar Z, Öngören Ş, Soysal T, Ferhanoğlu B, Aydın Y, Ülkü B, Aktuğlu G, Akman N; CHOP vs M-BACOD in Agressive Non-Hodgkin’s Lymphoma- Results of A Single Institution, XIIIth Meeting of The International Society of Hematology (European- African Division), Istanbul, Turkey, 3- 8 Sep 1995.
33. Özçelik T, Özbek U, Vural B, Bilgen H, Anak S, Gedikoğlu G, Beşışık S, Sargın D, Soysal T, Ferhanoğlu B, Tangün Y; Evaluation of Chimerism with DNA Polymorphisms in Bone Marrow Transplantation, XIIIth Meeting of The International Society of Hematology (European- African Division), İstanbul, Turkey, 3- 8 September, 1995.
34. Dinçer E, Demir M, Ferhanoğlu B, Başlar Z, Soysal T, Aydın Y, Ülkü B, Aktuğlu G, Akman N; Results of An Intensive Chemotherapy Protocol (BFM) in Adult ALL, XIIIth Meeting of The International Society of Hematology (European- African Division), İstanbul, Turkey, 3- 8 Sep 1995.
35. Demir M, Başlar Z, Soysal T, Ferhanoğlu B, Aydın Y, Ülkü B, Aktuğlu G, Akman N; Mitoxantrone, Etoposide, Intermediate Dose ARA-C Combination Chemotherapy Protocol in Resistant or Recurrent AML, XIIIth Meeting of The International Society of Hematology (European- African Division) İstanbul, Turkey, 3- 8 Sep 1995.
36. Ferhanoğlu B, Türemen E, Demir M, Soysal T, Altınkaya N, Aksoy F, Ilıkkan B, Özkan F; Acute Myeloblastic Leukemia in Pregnancy: A Report and Autopsy Findings of The Premature Baby, XIIIth Meeting of The International Society of Hematology (European- African Division) İstanbul, Turkey, 3- 8 Sep 1995.
37. Tanverdi L, Soysal T, Akman N, Ferhanoğlu B, Eralp Y; Moderate Dose ARA-C Induced Acute Cerebellar Syndrome, XIIIth Meeting of The International Society of Hematology (European- African Division) İstanbul, Turkey, 3- 8 Sep 1995.
38. Ferhanoğlu B, Eralp Y, Arun B, Soysal T, Avanoğlu Y, Ülkü B, Aktuğlu G, Akman N, Başlar Z; Cytokines in Multiple Myeloma. XIIIth Meeting of The International Society of Hematology (European- African Division) İstanbul, Turkey, 3- 8 Sep 1995.
39. Arun B, Eralp Y, Ferhanoğlu B; Soluble IL- 2 Receptors in Hematologic Malignancies, XIII. Meeting of the International Society of Hematology, Istanbul, 3- 8 Sep 1995, Abs. Nb. 619.
40. Ferhanoğlu B, Öngen Z, Soysal T, Ali V, Aykut S, Akman N; Fibrinogen, FVII, Apo (A) Values in Atherosclerosis Confirmed by Coronary Angiography, XXVth Congress of The International Society of Hematology. Cancun, Mexico, 17- 22 Apr 1994.
41. Ferhanoğlu B, Tanrıverdi L, Akman N; Moderetate Dose ARA-C Induced Cerebellar Toxicity, 24th Congress of the International Society of Haematology, South Bank Centre, London, UK, 23- 27 August 1992.
42. Ferhanoğlu B, Soysal T, Arun B, Köymen T, Calay Z, Tüzüner N, Avanoğlu Y, Ülkü B, Aktuğlu G, Akman N; Retrospective Analysis of 39 Myelodysplastic Cases. 24th Congress of The International Society of Haematology. London, UK, 23- 27 Aug 1992.
43. Ulutin ON, Çizmeci G, Özer M, Özsoy Y, Yardımcı T, Ulutin T, Ferhanoğlu B, Ulutin ŞB; The Clinical and Laboratory Results of Defibrotide on the Peripheric Obliterative Vascular Diseases, 7th European Congress of the International Union of Angiology and 3rd Mediterranian Congress of Angiology, Rhodes, Greece, p. 128, 26- 31 May 1991.
44. Wu KK, Sanduja R, Tsai AL, Loose-Mitchell DS and Ferhanoğlu B; Aspirin Inhibits Interleukin 1(IL-1) Induced Prostaglandin H(PGH) Synthase Expression in Cultured Endothelial Cells, International Society of Hematology, 23th Congress, American Society of Hematology 31th Annual Meeting,Blood, 76: Suppl 1, 2087, Nov 28- Dec 4 1990.
45. Ferhanoğlu B and Wu KK; Tumor Necrosis Factor (TNF) Stimulates Endothelial Cell Prostacyclin Production by Inducing De Novo Synthesis of Prostaglandin H (PGH) Synthase (Cyclooxygenase), International Society of Hematology, 23th Congress, American Society of Hematology 31th Annual Meeting, Blood, 76: Suppl. 1, 2014, Boston, Nov 28- Dec 4 1990.
46. Tabak F, Ferhanoğlu B, Yücel A, Mamal M, Bohar H, İmeryüz N, Avanoğlu Y, Ulutin ON, Akman N; Comparison of Piperacillin+Amikacin Versus Ceftizoxime+Amikacin Combinations in the Tretment of Febrile Neutropenic Patients, 5th Meeting of the Mediteranian Blood Club, Antalya, Turkey, 21- 24 Sep 1990.
47. Ferhanoğlu B, Tabak F, Avanoğlu Y, Aktuğlu G, Ulutin ON, Akman N; Comparision of Aclacynomycin +ARA-C Versus DAT Combination Chemotherapy in the Treatment of ANLL, 5th Meeting of the Mediterranian Blood Club, Antalya, Turkey, 21- 24 Sep 1990.
48. Soysal T, Avanoğlu Y, Ferhanoğlu B, Ülkü B, Aktuğlu G, Ulutin ON, Akman N; A Retrospective Study of 96 Cases of Chronic Lymphocytic Leukemia, 5th Meeting of The Mediterranean Blood Club, Antalya, Turkey, 21- 24 Sep 1990.
49. Ulutin ON, Ulutin SB, Uğur MS, Ulutin T, Erbengi T, Ferhanoğlu B and Yardımcı T; Defibrotide and Its Effects on Platelet Functions, 6th.Meeting of the Danubian League Against Thrombosis and Haemorrhagic Disorders, p.48, Vienna, Austria, 1989.
50. Ferhanoğlu B, Avanoğlu Y, Tüzüner N, Erbengi T, Ulutin ON; Acute Megakaryoblastik Leukemia (Report of A Case). XXII Congress of the International Society of Hematology, p. 372, Milan, Italy, Aug 28- Sep 2 1988.
51. Ulutin B, Ulutin T, Özsoy Y, Ferhanoğlu B and Ulutin ON; The Effects of Defibrotide on Tissue Plasminogen Activator and Molecular Markers of Platelets. Xth International Congress on Thrombosis, p.153, Athens, Greece, May 22- 27, 1988.

Citations – Web of Science

Citation Reports

1. Wu KK, Sanduja R, Tsai AL, Ferhanoglu B, Loosemitchell DS. ASPIRIN INHIBITS INTERLEUKIN-1-INDUCED PROSTAGLANDIN-H SYNTHASE EXPRESSION IN CULTURED ENDOTHELIAL-CELLS. Proceedings of the National Academy of Sciences of the United States of America. 1991; 88(6): 2384-7.10.1073/pnas.88.6.2384.WOS:A1991FC21600074.Times Cited: 129.
2. Pamuk GE, Pamuk ON, Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. Overview of 321 patients with idiopathic thrombocytopenic purpura – Retrospective analysis of the clinical features and response to therapy. Annals of Hematology. 2002; 81(8): 436-40.10.1007/s00277-002-0488-x.WOS:000178399600004.Times Cited: 45.
3. Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P, Warden J, Stevens L, Pocock CFE, Miall F, Cunningham D, Davies J, Jack A, Stephens R, Walewski J, Ferhanoglu B, Bradstock K, Linch DC. Rituximab versus a watch-and-wait approach in patients with advanced- stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncology. 2014; 15(4): 424-35.10.1016/s1470-2045(14)70027-0.WOS:000334301900040.Times Cited: 29.
4. Aki H, Tuzuner N, Ongoren S, Baslar Z, Soysal T, Ferhanoglu B, Sahinler I, Aydin Y, Ulku B, Aktuglu G. T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma. Leukemia Research. 2004; 28(3): 229-36.10.1016/s0145-2126(03)00253-4.WOS:000189082600006.Times Cited: 19.
5. Aydingoz IE, Ferhanoglu B, Guney O. Does tissue iron status have a role in female alopecia? Journal of the European Academy of Dermatology and Venereology. 1999; 13(1): 65-7.10.1111/j.1468-3083.1999.tb00849.x.WOS:000083371100013.Times Cited: 13.
6. Baslar Z, Soysal T, Hanci M, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B. Successful outcome of aspergillus brain abscess in a patient who underwent bone marrow transplantation for aplastic anemia. Haematologia. 1997; 28(4): 265-71WOS:A1997YK20900011.Times Cited: 13.
7. Baslar Z, Soysal T, Aygun G, Ferhanoglu B, Sarioglu AC, Ulku B. Successfully treated invasive central nervous system aspergillosis in an allogeneic stem cell transplant recipient. Bone Marrow Transplantation. 1998; 22(4): 404-5.10.1038/sj.bmt.1701357.WOS:000075416200018.Times Cited: 4.
8. Erman M, Akova M, Akan H, Korten V, Ferhanoglu B, Koksal I, Cetinkaya Y, Uzun O, Unal S, Febrile Neutropenia Study Grp T. Comparison of cefepime and ceftazidime in combination with amikacin in the empirical treatment of high-risk patients with febrile neutropenia: A prospective, randomized, multicenter study. Scandinavian Journal of Infectious Diseases. 2001; 33(11): 827-31.10.1080/00365540110076679.WOS:000172095200008.Times Cited: 10.
9. Ozbalak M, Cetiner M, Bekoz H, Atesoglu EB, Ar C, Salihoglu A, Tuzuner N, Ferhanoglu B. Azacitidine has limited activity in ‘real life’ patients with MDS and AML: a single centre experience. Hematological Oncology. 2012; 30(2): 76-81.10.1002/hon.986.WOS:000304800800004.Times Cited: 9.
10. Sili U, Yilmaz M, Ferhanoglu B, Mert A. Candida krusei arthritis in a patient with hematologic malignancy: Successful treatment with voriconazole. Clinical Infectious Diseases. 2007; 45(7): 897-8.10.1086/521253.WOS:000249237900013.Times Cited: 8.
11. Ozen S, Ferhanoglu B, Senocak M, Tuzuner N. Idiopathic myelofibrosis (agnogenic myeloid metaplasia): Clinicopathological analysis of 32 patients. Leukemia Research. 1997; 21(2): 125-31.10.1016/s0145-2126(96)00095-1.WOS:A1997WQ26600006.Times Cited: 8.
12. Ar MC, Ozbalak M, Tuzuner N, Bekoz H, Ozer O, Ugurlu K, Tabak F, Ferhanoglu B. Severe Bone Marrow Failure Due to Valganciclovir Overdose After Renal Transplantation From Cadaveric Donors: Four Consecutive Cases. Transplantation Proceedings. 2009; 41(5): 1648-53.10.1016/j.transproceed.2009.02.093.WOS:000267449100048.Times Cited: 8.
13. Sayman HB, Sonmezoglu K, Altiok E, Devranoglu G, Ferhanoglu B. UNEXPECTED BONE-MARROW UPTAKE OF TL-201 IN NONSECRETORY MYELOMA. Journal of Nuclear Medicine. 1995; 36(2): 250-1WOS:A1995QE71400023.Times Cited: 7.
14. Eskazan AE, Soysal T, Ongoren S, Gulturk E, Ferhanoglu B, Aydin Y. Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy. Haematologica-the Hematology Journal. 2011; 96(3): E15-E.10.3324/haematol.2011.040048.WOS:000288767000027.Times Cited: 6.
15. Tokmak H, Ergonul O, Demirkol O, Cetiner M, Ferhanoglu B. Diagnostic contribution of F-18-FDG-PET/CT in fever of unknown origin. International Journal of Infectious Diseases. 2014; 19: 53-8.10.1016/j.ijid.2013.10.009.WOS:000329981700009.Times Cited: 5.
16. Eskazan AE, Ongoren S, Ar MC, Soysal T, Ferhanoglu B, Aki H, Aydin Y. Essential Thrombocythemia and Multiple Myeloma: Two Rare Diseases in One Patient. Clinical Lymphoma Myeloma & Leukemia. 2011; 11(5): 442-5.10.1016/j.clml.2011.04.001.WOS:000295792800011.Times Cited: 4.
17. Arslan F, Tabak F, Avsar E, Midilli K, Mert A, Ozaras R, Soysal T, Ozturk R, Ferhanoglu B. Ganciclovir-resistant cytomegalovirus encephalitis in a hematopoietic stem cell transplant recipient. Journal of Neurovirology. 2010; 16(2): 174-8.10.3109/13550281003682539.WOS:000277365100008.Times Cited: 5.
18. Saydam G, Haznedaroglu IC, Temiz Y, Soysal T, Sucak G, Tombuloglu M, Ozdogu H, Yavuz S, Altintas A, Ozet G, Gulbas Z, Ferhanoglu B, Ilhan O. Retrospective Evaluation of Patients Treated with Dasatinib for Philadelphia Positive Leukemias: Turkish Experience of 16 Months. Uhod-Uluslararasi Hematoloji-Onkoloji Dergisi. 2009; 19(4): 195-204WOS:000273130700001.Times Cited: 5.
19. Pamuk ON, Pamuk GE, Soysal T, Ongoren N, Baslar ZB, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. Chronic lymphocytic leukemia in Turkey: Experience of a single center in Istanbul. Southern Medical Journal. 2004; 97(3): 240-5WOS:000222171900007.Times Cited: 5.
20. Giles FJ, Shan JQ, Advani SH, Akan H, Aydogdu I, Aziz Z, Azim HA, Bapsy PP, Buyukkececi F, Chaimongkol B, Chen PM, Cheong SK, Ferhanoglu B, Hamza R, Khalid HM, Intragumtornchai T, Kim SW, Kim SY, Koc H, Kumar L, Kumar R, Lei KI, Lekhakula A, Muthalib A, Patel M, Poovalingam VP, Prayoonwiwat W, Rana F, Reksodiputro AH, Ruff P, Sagar TG, Schwarer AP, Song HS, Suh CW, Suharti C, Supindiman I, Tee GY, Thamprasit T, Villalon AH, Wickham NR, Wong JE, Yalcin A, Jootar S. A prospective randomized study of CHOP versus CHOP plus alpha-2B interferon in patients with intermediate and high grade non-Hodgkin’s lymphoma: The International Oncology Study Group NHL1 study. Leukemia & Lymphoma. 2000; 40(1-2): 95-103.10.3109/10428190009054885.WOS:000166585600009.Times Cited: 5.
21. Yilmaz M, Eskazan AE, Unsal A, Taninmis H, Kara E, Cetiner M, Ferhanoglu B. Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature. Transfusion. 2013; 53(7): 1586-93.10.1111/j.1537-2995.2012.03944.x.WOS:000321612400028.Times Cited: 4.
22. Ure UB, Ar MC, Salihoglu A, Guner SI, Baran A, Oguz O, Ferhanoglu B. Alemtuzumab in Sezary syndrome: efficient but not innocent. European Journal of Dermatology. 2007; 17(6): 525-9WOS:000252112200010.Times Cited: 4.
23. Ferhanoglu B, Ongoren S, Ar CM, Uzel B, Forta H, Necioglu D. Intrathecal methotrexate-induced acute cerebellar syndrome. Annals of Hematology. 2003; 82(4): 241-3.10.1007/s00277-003-0618-0.WOS:000183095700008.Times Cited: 3.
24. Ulutin ON, BalkuvUlutin S, BezerGoker B, Cizmeci G, Ferhanoglu B, Ozsoy Y, Ugur MS, Ulutin T, Yaman A, Yardimci T. Effect of defibrotide on platelet function. Seminars in Thrombosis and Hemostasis. 1996; 22: 21-4WOS:A1996UV12400005.Times Cited: 4
25. Soysal T, Ferhanoglu B, Bilir M, Akman N. OCULOMOTOR NERVE PALSY ASSOCIATED WITH VINCRISTINE TREATMENT. Acta Haematologica. 1993; 90(4): 209-10WOS:A1993NG15000011.Times Cited: 4.
26. Tiryakioglu O, Kadioglu P, Ongoren S, Acbay O, Ferhanoglu B, Gundogdu S, Korugan U. An unusual cause of hypercalcemia in polycythemia vera: Parathyroid adenoma. Acta Medica Okayama. 2002; 56(3): 167-70WOS:000176521200007.Times Cited: 3.
27. Baslar Z, Ongoren S, Soysal T, Ferhanoglu B, Aktuglu G, Ulkii B. Extramedullary relapse after allogeneic stem cell transplantation. Bone Marrow Transplantation. 1999; 23: S2-SWOS:000079562900006.Times Cited: 3
28. Ferhanoglu B, Erzin Y, Baslar Z, Tuzuner HAN. Secondary amyloidosis in the course of idiopathic myelofibrosis. Leukemia Research. 1997; 21(9): 897-8.10.1016/s0145-2126(97)00049-0.WOS:A1997YG70400016.Times Cited: 3.
29. Eskazan AE, Eyice D, Kurt EA, Elverdi T, Yalniz FF, Salihoglu A, Ar MC, Aydin SO, Baslar Z, Ferhanoglu B, Aydin Y, Tuzuner N, Ozbek U, Soysal T. Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion. Leukemia Research. 2014; 38(7): 781-7.10.1016/j.leukres.2014.04.004.WOS:000339339400010.Times Cited: 2.
30. Sahin F, Saydam G, Comert M, Uz B, Yavuz AS, Turan E, Yonal I, Atay H, Keltikli E, Turgut M, Pehlivan M, Akay MO, Gurkan E, Paydas S, Kahraman S, Demirkan F, Kirkizlar O, Akpinar S, Pamuk GE, Demir M, Ozbas HM, Sonmez M, Gulturk M, Salihoglu A, Eskazan AE, Ar C, Sahin HH, Ongoren S, Baslar Z, Aydin Y, Yenere MN, Tuzuner N, Ferhanoglu B, Haznedaroglu IC, Ilhan O, Soysal T. Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients. Turkish Journal of Hematology. 2013; 30(4): 351-8.10.4274/tjh.2013.0151.WOS:000331341700002.Times Cited: 2.
31. Ongoren S, Tarkan-Arguden Y, Ar MC, Yilmaz S, Ure U, Kuru D, Eskazan AE, Guven GS, Cetin G, Cirakoglu A, Baslar Z, Deviren A, Aydin Y, Hacihanefioglu S, Ferhanoglu B, Tuzuner N, Ulku B, Soysal T. Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Results of a Single Center. Turkiye Klinikleri Tip Bilimleri Dergisi. 2009; 29(2): 321-30WOS:000266016400004.Times Cited: 2.
32. Pamuk GE, Pamuk ON, Soysal T, Ongoren S, Baslar Z, Ferhanoglu B, Aydin Y, Ulku B, Aktuglu G, Akman N. An overview of young CLL patients: a single-centre experience from Turkey. Haematologia. 2002; 31(4): 303-11WOS:000175706400003.Times Cited: 2.
33. Salihoglu A, Elverdi T, Karadogan I, Paydas S, Ozdemir E, Erdem G, Karadurmus N, Akyol G, Kaynar L, Yegin ZA, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Ferhanoglu B. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Annals of Hematology. 2015; 94(3): 415-20.10.1007/s00277-014-2215-9.WOS:000349225200007.Times Cited: 1.
34. Ozbalak M, Tokatli I, Ozdemirli M, Tecimer T, Ar MC, Ornek S, Koroglu A, Laleli Y, Ferhanoglu B. Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(-) EBV(-) HHV8(+) patient. European Journal of Haematology. 2013; 91(5): 467-9.10.1111/ejh.12174.WOS:000328464600007.Times Cited: 1.
35. Leonard J, Reeves J, Ferhanoglu B, Doner KT, Eom H, Flinn IW, Raposo J, Chowhan NM, Suh C, Noga S, Tumyan G, Aung S, Hajdenberg J, Ulrich BK, Pendergrass KB, Mulligan G, Rizo A, Kussick S, Offner F. PYRAMID and LYM2034: Targeted randomized phase II studies of bortezomib with or without immunochemotherapy in newly diagnosed nongerminal center B-cell-like (GCB) diffuse large B-cell lymphoma (DLBCL), including rapid prospective non-GCB subtype identification. Journal of Clinical Oncology. 2011; 29(15): WOS:000208880304651.Times Cited: 1
36. Tarkan-Arguden Y, Ar MC, Yilmaz S, Ongoren S, Kuru D, Ure U, Cirakoglu A, Eskazan AE, Guven GS, Cetin G, Purisa S, Baslar Z, Deviren A, Aydin Y, Hacihanefioglu S, Ferhanoglu B, Tuzuner N, Ulku B, Soysal T. CYTOGENETIC CLONAL EVOLUTION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA. Biotechnology & Biotechnological Equipment. 2009; 23(4): 1515-20.10.2478/v10133-009-0022-6.WOS:000272201400022.Times Cited: 1.
37. Igdem S, Okkan S, Uenalan B, Igdem A, Ferhanoglu B. Cervical cancer coexisting with small lymphocytic lymphoma detected during positron emission tomography/computed tomography simulation: a case report. European Journal of Gynaecological Oncology. 2008; 29(4): 405-7WOS:000257220000023.Times Cited: 1.
38. Hatirnaz M, Ure U, Ar C, Akyerli C, Soysal T, Ferhanoglu B, Oezcelik T, Ozbek U. The SOCS-1 gene methylation in chronic myeloid leukemia patients. American Journal of Hematology. 2007; 82(8): 729-30.10.1002/ajh.20886.WOS:000248749300008.Times Cited: 0.
39. Ozbek U, Vural B, Kalayoglu S, Soysal T, Bilgen H, Yavuz S, Anak S, Sargin D, Gedikoglu G, Ferhanoglu B, Akoglu T, Tangun Y, Ozcelik T. Evaluation of chimerism with DNA polymorphisms in bone marrow transplantation. Turkish Journal of Pediatrics. 1997; 39(3): 303-11WOS:A1997XZ02900003.Times Cited: 1.

Papers Published in National Journals

1. Öngören Ş, Argüden YT, Ar MC, Yılmaz Ş, Üre ÜB, Kuru D, Eşkazan AE, Güven GS, Çetin G, Çırakoğlu A, Başlar Z, Deviren A, Aydın Y, Hacıhanefioğlu S, Ferhanoğlu B, Tüzüner N, Ülkü B, Soysal T; “Clonal Chromosomal Abnormalities in Philadelphia-Negative Cells and Their Clinical Significance in Patients with Chronic Myeloid Leukemia: Result of a Single Center”, Turkiye Klinikleri Med Sci, 29(2), 321-330 (2009).
2. Üre Ü, Ar MC, Başlar Z, Soysal T, Öngören Ş, Gülseven M, Aydın Y, Ülkü B, Tüzüner N, Ferhanoğlu B; “The Effect of ZAP-70 Expression on Disease Progression in Early Stage (Binet A) B-CLL Patients”, Trakya Univ Tip Fak Derg, 2009.
3. Öngören Ş., Başlar Z., Soysal T., Ar M. C., Sonsuz A., Özbay G., Ferhanoğlu B. Case Report of Two Haematopoietic Stem Cell Transplanted Patients with Chronic Graft-versus- Host Disease Resembling Acute Viral Hepatitis. Turk J Haematol.; 22(1): 45- 48, 2005.
4. Başlar Z., Soysal T., Ferhanoğlu B, Öngören Ş., Üre Ü., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Hematopoetic Stem Cell Transplantation Activity at a Single Center: Cerrahpaşa Experience. Turk J Hematol. 19(2): 317-329, 2002.
5. Öngören Ş., Akı H., Eralp Y., Soysal T., Tüzüner N., Ferhanoğlu B. Villoz Lenfositli Splenik Lenfoma Tanısı ile İzlenen Bir Olgu. Klinik Gelişim; 12: 912– 916, 1999.
6. Çetinkaya A., Ar M. C., Öngören Ş., Küçükyılmaz H., Ferhanoğlu B. Tiklopidin’e Bağlı Agranulositoz: Olgu Bildirimi. Klinik Gelişim; 12: 792- 794, 1999.
7. Demir M., Başlar Z., Soysal T., Ferhanoğlu B., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Dirençli veya Yineleyen ANLL’de Mitxantrone, Etoposide ve Orta Doz ARA-C Kemoterapi Protokolü. Cerrahpaşa Tıp Fak. Der.; 28: 48- 52, 1997. (Uluslararası Hematoloji Derneği ISH- European- African Division XIII. Kongresinde de tebliğ edilmiştir.)
8. Özbek U., Vural B., Kalayoglu S., Soysal T., Bilgen H., Yavuz S., Anak S., Sargın D., Gedikoğlu G., Ferhanoğlu B., Akoğlu T., Tangün Y., Özçelik T. Evaluation of Chimerism with DNA Polymorphisms in Bone Marrow Transplantation. Turkish Journal of Pediatrics; 39: 303 – 311, 1997. (I.National Bone Marrow and Stem Cell Transplantation Congress, Ankara,3- 4 Mayıs 1996’da ayrıca tebliğ edilmiştir.)
9. Ferhanoğlu B. Hematopoetik ve İmmun Sistemin Yeniden Yapılanması. Klinik Gelişim; 10, 1997.
10. Ferhanoğlu B. Akrabadışı (Unrelated) Donörden Kemik İliği Transplantasyonu. Klinik Gelişim; 10, 1997.
11. Ferhanoğlu B., Demir M. Transplantasyonda İmmunTolerans. Klinik Gelişim; 10, 1997.
12. Akan A., Akoğlu T., Berk Ö., Ertok Ş., Ferhanoğlu B., Gedikoğlu G., Tangün Y., Tanyeli A., Tuncer M. Bone Marrow Transplantation in Turkiye. Annual Report of Turkish BMT Registry, Bone Marrow Transplantation; 12: 531 Suppl. 1, 1996.
13. Oğuz O., Başlar Z., Soysal T., Mercan E., Ferhanoğlu B. Kronik Kutanöz Graft Versus Host Hastalığı Olgusu. Deri Hastalıkları Ve Frengi Arşivi. (Türk Derm.); 30: 39m- 42, 1996.
14. Uras C., Ertürk M. S., Yardımcı H., Başlar Z., Soysal T., Ferhanoğlu B. İmmun (İdyopatik ) Trombositopenik Purpura Tedavisinde Splenektomi. Cerrahpaşa Tıp Fak. Der.; 27: 85– 89, 1996.
15. Akün E., Soysal T., Ferhanoğlu B., Tüzüner N., Akman N. Granülositik Sarkom (3 Olgu Nedeniyle). Cerrahpaşa Tıp Fak. Der.; 26: 165- 167, 1995.
16. Ferhanoğlu B., Eralp Y., Hız M., Tüzüner N., Akman N. Primer Kemik Lenfoması ile İzlediğimiz 3 Olgu, Cerrahpaşa Tıp Fak.Der.; 26: 165- 167, 1995.
17. Ferhanoğlu B. Akut Lenfoblastik Lösemi Tedavisinde Gelişmeler, Klinik Gelişim; 8: 3981- 3987, 1995.
18. Ferhanoğlu B. Akut Myeloid Lösemi Tedavisi, Klinik Gelişim; 8: 3988- 3990, 1995.
19. Soysal T., Ferhanoğlu B., Tunçkale A., Aydın Y., Akman N. Trombotik Trombositopenik Purpura Olgularımız, Cerrahpaşa Tıp Fak. Der. 25: 233- 241, 1994. (XXIII. Ulusal Hematoloji Kongresinde ayrıca tebliğ edilmiştir.)
20. Ferhanoglu B. Soysal T. Tanriverdi L., Akman N. Moderate Dose ARA-C Induced Cerebellar Toxicity. Journal of the Cerrahpasa Medical Faculty; 25: 577-579, 1994.
21. Dinçer E., Soysal T., Bilir M., Ferhanoğlu B. Akut Promyelositik Lösemi Tedavisinde All- Trans Retinoik Asid Kullanımı ve Yan Etki Olarak Gelişen Retinoik Asid Sendromu, Cerrahpaşa Tıp Fak. Der.; 25: 441- 444, 1994.
22. Tabak F., Soysal T., Ferhanoğlu B., Avanoğlu Y. A., Aktuğlu G., Ülkü B., Tüzüner N., Akman N. Hodgin Hastalığı ve Kemik İliği Tutulumu. Cerrahpaşa Tıp Fak. Der.; 25: 449- 453, 1994.
23. Dinçer E., Soysal T., Ferhanoğlu B. Tüylü Hücreli Lösemide Yaygın ve Büyük Karın İçi Lanfadenomegali. Cerrahpaşa Tıp Fak. Der.; 25: 445- 447, 1994.
24. Tüzüner N., Doğusoy G., Ülkü B., Ferhanoğlu B., Soysal T., Molinas N., Baliç A., Büyükünal E, Aydın Y., Aktuğlu G., Akman N. Non- Hodgkin Lenfomalarda Kemik İliği Tutulumu, Klinik Gelişim; 7: 2982 – 2986, 1994.
25. Ferhanoglu B., Soysal T., Tanriverdi L., Akman N. Moderate Dose ARA-C Induced Cerebellar Toxicity. Journal of the Cerrahpasa Medical Faculty; 25: 577-579, 1994.
26. Soysal T., Ferhanoğlu B., Aydın Y., Ülkü B., Aktuğlu G., Akman N. İzlediğimiz 127 Kronik Lenfositik Lösemi Olgusunun Geriye Dönük İncelenmesi, Cerrahpaşa Tıp Fak. Der.; 24: 413- 421, 1993.
27. Soysal T., Tabak F., Ferhanoğlu B., Aydın Y., Aktuğlu G., Ülkü B., Bilir M., Akman N. Hodgkin Hastalığında MOPP Kemoterapisinin Sonuçları, Klinik Gelişim; 6: 2845- 2849, 1993.
28. Aydemir E. H., Ferhanoglu B., Oğuz O., Akçakaya N., Tozakı S., Avanoglu Y., Gozukara Y. Hyper IgE Syndrome Amiloidosis and Developmental Defect, Turkish Journal of Medical and Biological Research; 3: 305- 309, 1992.
29. Döver F., Ferhanoğlu B., Avanoğlu Y., Akman N. Herediter Sideroblastik Anemili Üç Erkek Kardeş, Klinik gelişim; 4:957- 959, 1992.
30. Örnek E., Aktuğlu G., Ferhanoğlu B., Avanoğlu Y., Akman N., Müftüoğlu A., Ülkü B., Ulutin O. N. FAB Sınıflamasına Göre Analiz Edilmiş 19 Myelodisplastik Sendrom Olgusu, Cerrahpaşa Tıp Fak. Der.; 22:317-321, 1991.
31. Tabak F., Ferhanoğlu B., Yücel A., Mamal M., Bahar H., İmeryüz N., Avanoğlu Y., Ulutin O. N., Akman N. Febril Nötropenik Hastalarda Ceftizoksim+ Amikasin ile Piperasilin+ Amikasin Kombine Tedavilerinin Karşılaştırılması, Klinik Gelişim; 4: 1013- 1016, 1991.
32. Ferhanoğlu B., Ataman R., Gülseven M., Akman N. Hemaferezis: Endikasyonları,Yan Etkileri, 78 Hemaferez İşleminden Aldığımız Sonuçlar, Cerrahpaşa Tıp Fak.Der.; 21: 369- 376, 1990.
33. Ferhanoğlu B., Avanoglu Y., Çakalın C., Tüzüner N., Erdoğan N., Çiftçi İ., Akman N. Richter’s Syndrome. Diffuse Immunoblastic Lymphoma in Patients with Chronic Lymphocytic Leukemia, Hacettepe Medical Journal; 22; 227- 233, 1989.
34. Avanoğlu Y., Ferhanoğlu B., Tüzüner N., Aktuğlu G., Ülkü B., Akman N., Müftüoğlu A., Ulutin O.N. Hodgkin Hastalığı ve Akut Lösemi, Cerrahpaşa Tıp Fak. Der.; 20: 45- 48, 1989.
35. Ferhanoğlu B. Hiperkoagülabilite ve Tromboz, Türkiye Klinikleri; 9: 333- 340, 1989.
36. Ferhanoğlu B., Tabak F., Avanoğlu Y., Tüzüner N., Ulutin O. N. Akut Lösemiye Dönüşen Bir Multipl Myelom Olgusu, Klinik Gelişim; 2: 505-511, 1989.
37. Ferhanoğlu B., Ülkü B., Aktuğlu G., Avanoğlu Y., Akman N. Akut Lösemi ve Gebelik, Klinik gelişim; 2: 600- 602, 1989.
38. Ferhanoğlu B., Avanoğlu Y., Mercan F., Aydemir İ., Eyüboğlu E., Müftüoğlu A., Ulutin O.N. Konjenital FXIII Eksikliği Olgusu, Klinik Gelişim; 1: 285- 287, 1988.
39. Ferhanoğlu B., Tabak F., Avanoğlu Y., Aktuğlu G., Ülkü B., Tüzüner N., Akman N., Müftüoğlu A., Ulutin O. N. Myelofibroz (34 Olgunun Geriye Dönük İncelenmesi) Cerrahpaşa Tıp Fak. Der.; 19: 187- 193, 1988.
40. Ferhanoğlu B. Akut Lösemide Destek Tedavisi, Klinik Gelişim, 1: 305- 311, 1988.
41. Ülkü B., Türkçüoğlu K., Müftüoğlu A., Aktuğlu G., Akman N., Ulutin O., Avanoğlu Y., Ferhanoğlu B. Hodgkin Lenfomasında Remisyon Süresini Etkileyen Prognostik Faktörler, Hematoloji IX; 467- 476, 1987.
42. Suna D., Avanoğlu Y., Ferhanoğlu B., Tüzüner N., Ulusoy N., Ülkü B., Müftüoğlu A. Bir Doğal Deneme; İmmun Yetersizlik, Hodgkin Hastalığı, Amiloidoz, Hematoloji IX; 562- 567, 1987.
43. Avanoğlu Y., Ferhanoğlu B., Topuz B., Gençoğlu A., Akman N., Müftüoğlu A., Ulutin O. N. Akut NonLenfoblastik Lösemide Birleşik İlaç Tedavi Sonuçları, Hematoloji IX; 315- 324, 1987.
44. Ferhanoğlu B., Avanoğlu Y., Aktuğlu G., Ülkü B., Akman N., Müftüoğlu A., Ulutin O. N. Kronik Lenfoid Lösemi ve Kronik Myeloid Lösemide Sekonder Malignite, Hematoloji; 301- 308, 1987.
45. Ferhanoğlu B., Avanoğlu Y., Aktuğlu G., Ülkü B., Akman N., Müftüoğlu A., Ulutin O. N. Kronik Myeloid Lösemide Prognozu Etkileyen Faktörler ve Sürvi, Hematoloji; 297- 301, 1987.
46. Ferhanoğlu B., Ekmekçi A., Canberk A., Meriç M. Esansiyel Hipertansiyon Vakalarında Eritrosit Sıvı Hacim Değişikler, I.Ulusal Beta Reseptör Blokerleri Sempozyumu, İzmir, 6-9 Mayıs 1982.

Presentation in National Conferences

1. Burhan Ferhanoğlu, Lenfomada Allogeneik Hematopoetik Kök Hücre Nakli, 8. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, 6-8 Mart 2014, Antalya.
2. Ayşe Salihoğlu, Tuğrul Elverdi, İhsan Karadoğan, Semra Paydaş, Evren Özdemir, Gökhan Erdem, Nuri Karadurmuş, Gülşah Akyol, Leylagül Kaynar, Zeynep Arzu Yeğin, A. Gülsan Sucak, Vildan Özkocaman, Pervin Topçuoğlu, Muhit Özcan, Teoman Soysal, Burhan Ferhanoğlu, Nüks/Dirençli CD30+ Habis Kan Hastalıklarında Brentuksimab Vedotin: 9 Merkezin Deneyimi, 39. Ulusal Hematology Kongresi, 8th Balkan Day of Hematology, 25 Ekim 2013, Antalya, Türkiye.
3. Kuru R.D., Çirakoğlu A., Tarkan Argüden Y., Yilmaz Ş., Ar M., Öngören Ş., Başlar Z., Soysal T., Ferhanoğlu B., Aydin Y., Deviren A., Hacihanefioğlu S., Çeşitli Lösemi Türlerinde Kromozom 1 Düzensizlikleri., XII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, ANTALYA, TÜRKİYE, 27-30 Ekim 2011, cilt.31, no.6
4. Aslaneli Çakmak B., Tarkan Argüden Y., Çinar A., Kuru R.D., Yilmaz Ş., Gültürk E., Eşkazan A., Ar M., Başlar Z., Ferhanoğlu B., Aydin Y., Hacihanefioğlu S., Deviren A., Multipl Myelom Olgularına Ait Sitogenetik Bulgular., Ulusal Tıbbi Biyoloji ve Genetik Kongresi , ANTALYA, TÜRKİYE, 27-30 Ekim 2011, cilt.31, no.6.
5. Döşkaya H.E., Yilmaz Ş., Tarkan Argüden Y., Çirakoğlu A., Kuru R.D., Salihoğlu A., Eşkazan A.E., Soysal T., Ferhanoğlu B., Aydin Y., Hacihanefioğlu S., Deviren A., Öngören Aydin Ş., Kll Olgularında Gözlenen Kromozom Bulguları, XII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, ANTALYA, TÜRKİYE, 27-30 Ekim 2011, cilt.31, no.6.
6. Şeker N., Çirakoğlu A., Kuru R.D., Yilmaz Ş., Tarkan Argüden Y., Salihoğlu A., Eşkazan A., Ar M., Soysal T., Ferhanoğlu B., Hacihanefioğlu S., Deviren A., Yetişkin Aml Olgularında Gözlenen Sitogenetik Değişimler., XII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, ANTALYA, TÜRKİYE, 27-30 Ekim 2011, cilt.31, no.6.
7. Yilmaz Ş., Çirakoğlu A., Aslaneli Çakmak B., Eşkazan A., Kuru R.D., Ar M., Tarkan Argüden Y., Öngören Ş., Yentur S.P., Kurt H., Birinci N., Sağci Güven G., Silahtaroğlu A., Deviren A., Başlar Z., Soysal T., Ferhanoğlu B., Aydin Y., Hacihanefioğlu S., Cenani A., Hematolojik Kanserlerde Sitogenetik Çalışmalar., 9. Ulusal Tıbbi Genetik Kongresi, İSTANBUL, TÜRKİYE, 1-5 Aralık 2010, cilt.78, no.1.
8. Kuru R.D., Eşkazan A., Tarkan Argüden Y., Öngören Ş., Yilmaz Ş., Ar M., Çirakoğlu A., Başlar Z., Deviren A., Ferhanoğlu B., Aydin Y., Soysal T., Hacihanefioğlu S., Ülkü B., Hematolojik Kanserlerde Gözlenen 1q Duplikasyonları, III. Multidisipliner Kanser Araştırma Sempozyumu, 14-17 Mart 2010, Bursa, Türkiye.
9. Özbalak M, Çetiner M, Birtaş E, Beköz H, Ferhanoğlu B.MDS ve Yaşlı AML hastalarında 5-Azasitidin Kullanımı. 36. Ulusal Hematoloji Kongresi, 3-7 Kasım 2010, Antalya.
10. M. Yılmaz, A. Ünsal, B. Döner, H. Tanınmış, Y. Koç, E. Ahbap, E. Kara, B. Ferhanoğlu, Tekrarlayan Trombotik Trombositopenik purpurada ADAMTS 13 eksikliği: Olgu sunumu, 26. Ulusal Nefroloji, Hipertansiyon, Diyaliz ve Transplantasyon Kongresi, Kasım 2009 Antalya, Türkiye.
11. Ferhanoğlu B. DBBHL’da Güncel Tedavi. III. Çukurova Hematoloji- Onkoloji Günleri, Adana, 10 Kasım 2007.
12. Çetiner M., Sucak G., Aydın F., Birtaş E.,Yozgatlıgil C., Kalaça S., Akı Z., 1Sevgi Kalayoğlu- Beşışık S., Ferhanoğlu B., Gülbaş Z., Uzay A., Kaygusuz I., Fıratlı- Tuğlular T., Bayık M. Hematopoyetik Kökhücre Yapılan Hastalarda Yaşam Kalitesinin Değerlendirilmesi. Turkish Journal of Hematology 24(4):84 Suppl. 1, Ankara, 16- 19 Ekim 2007.
13. Salihoğlu A., Öngören Ş., Ar M.C., Başlar Z., Soysal T., Aydın Y., Ülkü B., Ferhanoğlu B. Demir Eksikliği Anemisinde Etyoloji. Turkish Journal of Hematology 24(4): 106 Suppl. 1, Ankara, 16- 19 Ekim 2007.
14. Eşkazan E., Özer Ö., Peker K., Beköz H., Yüksel Ş., Altıok E., Ferhanoğlu B. Jak-2 V617F (+) Myeloproliferatif/ Myelodisplastik Hibrid Hastalık. Turkish Journal of Hematology 24(4): 126 Suppl. 1, Ankara, 16- 19 Ekim 2007.
15. Özer Ö., Beköz H., Uğurlu K., Eşkazan E., Tabak F., Öngen G., Tüzüner N., Akı H., Ferhanoğlu B. Hodgkin ve Non- Hodgkin Lenfoma Sonrası Pet (+) Lenfadenopati ile Ortaya Çıkan İki Sarkoidoz Olgusu. Turkish Journal of Hematology 24(4): 151 Suppl. 1, Ankara, 16- 19 Ekim 2007.
16. Özer Ö., Beköz H., Ferhanoğlu B. Düşük Dereceli Primer Osseus B Hücreli Lenfoma; İki Olgu Sunumu. Turkish Journal of Hematology 24(4): 152 Suppl. 1, Ankara, 16- 19 Ekim 2007.
17. Sağci Güven G., Çirakoğlu A., Kuru R.D., Tarkan Argüden Y., Yilmaz Ş., Deviren A., Hacihanefioğlu S., Öngören Ş., Ar M., Ferhanoğlu B., Başlar Z., Atipik Sitogenetik Bulgulu Kronik Miyeloid Lösemi’li Bir Olgu Sunumu., Multidispliner Kanser Araştırma Sempozyumu, BURSA, TÜRKİYE, 12-15 Mart 2006.
18. Öngören Ş., Başlar Z., Soysal T., Ar M. C., Sonsuz A., Özbay G., Ferhanoğlu B. Case Report of Two Haematopoietic Stem Cell Transplanted Patients with Chronic Graft-versus- Host Disease Resembling Acute Viral Hepatitis. Turk J Haematol. 22(1): 45- 48, 2005.
19. Yılmaz M, Ar C, Öngören Ş, Özaras R, Başlar Z, Soysal T, Mert A, Ferhanoğlu B, Aydın Y, Tabak F, Ülkü B, Aktuğlu G, Öztürk R. Nötropenik hastalarda ampirik antibiyoterapi, etkenler ve duyarlılıkları Cerrahpaşa Deneyimi, 6. Febril Nötropeni Sempozyumu, 24-27 Şubat 2005, Ankara, Program, Konuşma Özetleri ve Bildiriler Kitabı, P-036, s.165.
20. Çetiner,M., Kalaça,S., Birtaş,E., Kalayoğlu-Beşışık,S., Soysal,T., Sargın,D., Ferhanoğlu,B., Fıratlı-Tuğlular,T., Bayık,M., Hematopoietik Kök Hücre Nakli YapılanHastalarda Yaşam Kalitesinin Değerlendirilmesi (İstanbul Deneyimi, Pilot Çalışma). XXXI. Ulusal Hematoloji Kongresi, 37, Antalya, 2004.
21. Sohrabi P M, YILMAZ G, Midilli K, Aksözek A, Özdamar M, İskonova M, Ferhanoğlu B, Türkoğlu S, Altaş K: Transplantasyon hastaları ve yenidoğanlarda CMV infeksiyonlarının tanısı, XXXI Türk Mikrobiyoloji Cemiyeti toplantısı s.246, 2004.
22. Başlar Z., Soysal T., Ferhanoğlu B, Öngören Ş., Üre Ü., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Hematopoetic Stem Cell Transplantation Activity at a Single Center: Cerrahpaşa Experience. Turk J Hematol. 19(2): 317-329, 2002.
23. Uzel B, Ongoren S, Baslar Z, Soysal T, Ferhanoglu B, Aydın Y, Ulku B, Aktuglu G, Akman N. Kötü prognozlu Akut myeloid lösemilerde IDA-FLAG tedavisi. XXVIII. Ulusal Kanser Kongresi, 2000, İzmir-Türkiye.
24. Öngören Ş, Aytekin, Yıldırım B, Uzel B, Başlar Z, Soysal T, Ferhanoglu B, Aydın Y, Ülkü B, Aktuğlu G, Akman N. Kötü prognozlu AML olgularında mitoksantron, orta doz sitozin arabinozid, etoposid (EMA) tedavisi. XXVIII. Ulusal Kanser Kongresi, 2000, İzmir-Türkiye.
25. Demircioğlu M, Öngören Ş, Uzel B, Karadoğan İ, Akı H, Tüzüner N, Ündar L, Ferhanoğlu B. Paroksismal noktürnal hemoglobinüri (PNH) tanısında konvansiyonel yöntemler (Ham, sukroz lizis testi) ile jel testi ve flow sitometri yöntemlerinin karşılaştırılması. XXVIII. Ulusal Kanser Kongresi, 2000, İzmir-Türkiye.
26. Öngören Ş, Uzel B, Necioğlu D, Forta H, Ferhanoğlu B. Intra-tekal metotreksat sonrası gelişen serebellar sendrom. XXVIII. Ulusal Kanser Kongresi, 2000, İzmir-Türkiye.
27. Uzel B, Ongoren S, Baslar Z, Soysal T, Ferhanoglu B, Aydin Y, Akman N, Ulku B, Aktuglu G. Kronik miyeloproliferatif hastalıklarda tromboz ve hemoraji insidansı. 2. Ulusal İç Hastalıkları Kongresi, 2000, Antalya-Türkiye.
28. Başlar Z., Öngören Ş., Soysal T., Ferhanoğlu B., Uras C., Beşe N., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Hematopoetic Stem Cell Transplantation Activity at Cerrahpaşa Medical School Hospital. III.Ulusal Kemik İliği ve Periferik Kök Hücre Nakli Kongresi. Mersin, 3- 5 Haziran 1999.
29. Öngören Ş., Soysal T., Başlar Z., Ferhanoğlu B., Aydın Y., Tanrıöver V., Sonsuz A. Budd- Chiari Syndrome Complicating allogeneic Stem Cell Transplantation. III.Ulusal Kemik İliği ve Periferik Kök Hücre Nakli Kongresi. Mersin, 3- 5 Haziran 1999.
30. Başlar Z., Öngören Ş., Soysal T., Ferhanoğlu B., Aktuğlu G., Ülkü B. Recurrent Extramedullary Relapses After Allogeneic Stem Cell Transplantation. III. Ulusal Kemik İliği ve Periferik Kök Hücre Nakli Kongresi. Mersin, 3- 5 Haziran 1999.
31. Aytekin H., Öngören Ş., Yıldırım B., Başlar Z., Soysal T., Ferhanoğlu B., Aydın Y., ÜlküB., Aktuğlu G., Akman N. Yüksek riskli AML Olgularında Mitoksantron, Orta Doz Sitozin Arabinozid, Etoposid Tedavisi. XXVI. Ulusal Hematoloji Kongresi. Ankara, 31 Ekim- 3 Kasım 1998.
32. Öngören Ş. , Başlar Z., Soysal T., Ferhanoğlu B., Aydın Y., Aktuğlu G., Ülkü B., Akman N.. Akut Promyelositik Lösemide All-Transretinoik Asit Kullanımı. XXV. Ulusal Hematoloji Kongresi. İstanbul, 12- 15 Kasım 1997.
33. Öngören Ş., Başlar Z., Soysal T., Aydın Y., Ferhanoğlu B., Akman N. Saf Eritroid Dizi Aplazisi. XXV. Ulusal Hematoloji Kongresi. İstanbul, 12- 15 Kasım 1997.
34. Öngören Ş., Başlar Z., Soysal T., Ferhanoğlu B., Aydın Y., Aktuğlu G., Ülkü B., Akman N.. Kemik İliği Kök Hücre Naklinin Önemli Bir Komplikasyonu: Veno – Okluzif Karaciğer Hastalığı. XXV. Ulusal Hematoloji Kongresi. İstanbul, 12- 15 Kasım 1997.
35. Öngören Ş., Başlar Z., Soysal T., Ferhanoğlu B., Aydın Y., Aktuğlu G., Ülkü B., Akman N. Kök Hücre Naklinin Önemli Bir Komplikasyonu: Venookluzif Karaciğer Hastalığı. II. Ulusal Kemik İliği Ve Kök Hücre Nakli Kongresi, İstanbul, 29- 30 Mayıs 1997.
36. Soysal T., Başlar Z., Öngören Ş., Ferhanoğlu B., Aydın Y., Aktuğlu G., Ülkü B. , Akman N . Periferik Kök Hücre Nakli Sonuçlarımız. II Ulusal Kemik İliği Ve Kök Hücre Nakli Kongresi, İstanbul, 29- 30 Mayıs 1997.
37. Başlar Z., Öngören Ş., Soysal T., Ferhanoğlu B., Aydın Y., Aktuğlu G., Ülkü B., Akman N. Hematopoetik Kök Hücre Nakli Sonuçlarımız. II Ulusal Kemik İliği Ve Kök Hücre Nakli Kongresi, İstanbul, 29- 30 May 1997.
38. Başlar Z., Öngören Ş., Soysal T., Ferhanoğlu B., Aydın Y., Aktuğlu G., Ülkü B., Akman N. Akut Myeloid Lösemide Allotransplant Sonrası Nüks. II Ulusal Kemik İliği Ve Kök Hücre Nakli Kongresi, İstanbul, 29 – 30 Mayıs 1997.
39. Ferhanoğlu B., Soysal T., Başlar Z., Uras C., Ober A., Başaran M., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Stem Cell Transplantation- A Single Center Experience. I.National Bone Marrow And Stem Cell Transplantation Congress, Ankara, Turkey, 3 -4 May 1996.
40. Soysal T., Başlar Z., Ferhanoğlu B., Akman N. Acute Myeloid Leukemia Relapsing After Stem Cell Transplantation. I. National Bone Marrow and Stem Cell Transplantation Congress. Ankara, Turkey, 3 -4 May 1996.
41. Başlar Z., Soysal T., Hancı M., Aygün G., Ferhanoğlu B., Sarıoğlu A. Ç. Successful Treatment Of Aspergillus Brain Abscess İn A Transplanted Aplastic Anemia Patient. I. National Bone Marrow and Stem Cell Transplantation Congress, Ankara, Turkey, 3- 4 May 1996.
42. Özbek U., Vural B., Kalayoğlu S., Bilgen H., Soysal T., Aral S., Sargın D., Gedikoğlu G., Akoğlu T., Ferhanoğlu B., Tangün Y., Özçelik T. Evaluation Of Chimerism With DNA Polymorphisms in Bone Marrow Transplantation. I. National Bone Marrow and Stem Cell Transplantation Congress, Ankara, Turkey, 3- 4 May 1996.
43. Ferhanoğlu B., Soysal T., Başlar Z., Uras C., Başaran M., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Kemik İliği Transplantasyonu Sonuçlarımız. XXIV. Ulusal Hematoloji Kongresi, İstanbul, 11- 14 Nisan 1996.
44. Çurgunlu A., Başlar Z., Soysal T., Ferhanoğlu B., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Hodgkin Hastalığında Tedaviye İkincil Malignite Gelişimi. XXIV. Ulusal Hematoloji Kongresi, İstanbul, 11- 14 Nisan 1996.
45. Başlar Z., Soysal T., Hancı M., Ferhanoğlu B., Ülkü B., Sarıoğlu A. Ç. Kemik İliği Transplantasyonu Olan Aplastik Anemili Bir Hastada Gelişen Aspergillus Beyin Absesinin Başarılı Tedavisi. XXIV. Ulusal Hematoloji Kongresi, İstanbul, 11- 14 Nisan 1996.
46. Başlar Z., Oşar Z. E., Soysal T., Ferhanoğlu B., Aydın Y., Ülkü B., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Hodgkin-Dışı Lenfomada Klinik Özellikler ve Prognozu Etkileyen Faktörler- Bir Merkezin Sonuçları. XXIV. Ulusal Hematoloji Kongresi, İstanbul, 11- 14 Nisan 1996.
47. Ceylan B., Öngören Ş., Başlar Z., Soysal T., Ferhanoğlu B., Aydın Y., Ülkü B., Aktuğlu G., Akman N. Ekstranodal Hodgkin-Dışı Lenfoma- Bir Merkezin Deneyimi. XXIV.Ulusal Hematoloji Kongresi, İstanbul, 11- 14 Nisan 1996.
48. Akı H, Ar C, Ferhanoğlu B, Tüzüner N: Myelodisplastik Sendrom. Morfolojik Prognoz faktörleri. XXIV Hematoloji Kongresi, Mayıs 1996, İstanbul.
49. Özen S, Ferhanoğlu B, Doğusoy G, Tüzüner N. Idiopathic myelofibrosis clinicopathological analysis of 32 patients. XIIth Meeting of the International Society of Haematology, 3-8 September, İstanbul, 1995.
50. Ferhanoglu B., Soysal T., Tanriverdi L., Akman N. Moderate Dose ARA-C Induced Cerebellar Toxicity. Journal of the Cerrahpasa Medical Faculty, 25: 577- 579, 1994.
51. Ferhanoğlu B., Soysal T., Altınkaya N., Aksoy F, Ilıkkan B., Özkan F. Acute Myeloblastic Leukemia In Pregnancy: A Report and Autopsy Findings of The Premature Baby. Journal of the Cerrahpaşa Medical Faculty, 25: 719- 721, 1994.
52. Soysal T., Tunçkale A., Ferhanoğlu B., Aydın Y., Akman N. Trombotik Trombositopenik Purpura Olgularımız. XXIII. Ulusal Hematoloji Kongresi, İstanbul, 30 Eylül- 5 Ekim 1993.
53. Gözükara Y., Soysal T., Ferhanoğlu B., Aydın Y., Aktuğlu G., Ülkü B., Başlar Z., Akman N. Multiple Myeloma (100 Olgunun Geriye Dönük İncelenmesi). XXIII. Ulusal Hematoloji Kongresi, İstanbul, 30 Eylül- 5 Ekim 1993.
54. Ulutin O. N., Müftüoğlu A., Akman N., Aktuğlu G., Ülkü B., Aydın Y., Ferhanoğlu B., Soysal T. Son 30 Yıllık Doğumsal Faktör Eksikliği Olgularımızın Dökümü. XXIII. Ulusal Hematoloji Kongresi, İstanbul, 30 Eylül- 5 Ekim 1993.
55. T. Toksöz, G. Doğusoy, Y. Aydın, G. Aktuğlu, B. Ülkü, B. Ferhanoğlu ve ark. Multipl myelomda kemik iliği histolojisi: Hücre morfolojisi ve kemik iliği tutulum paterninin sağkalım üzerine etkisi. X. Ulusal Patoloji Kongresi. 3-7 Kasım 1992, Girne, Kıbrıs. Program ve Bildiri Özetleri Kitabı, sayfa no: 52.
56. N.Tüzüner, G. Doğusoy, B. Ferhanoğlu, E. Büyükünal, Y. Aydın, N. Molinas, B. Ülkü, G. Aktuğlu. Mikst ve büyük hücreli lenfomalarda parafin kesitlerine uygulanan UCHL-1 ve L-26 monoklonal antikorları ile T ve B hücreli lenfomaların dağılımı: Morfolojik, İmmunolojik ve klinik özellikler. XXII. Ulusal Hematoloji Kongresi. 21-25 Ekim 1991, İstanbul Özetler Kitabı, bildiri no: 33.
57. Ferhanoğlu B, Dobrucalı A, Tabak F, Avanoğlu Y, Öz F, Ulutin O. Kaposi sarkomu ve interferon. 21. Ulusal Hematoloji Kongresi ve 1.Ulusal kemoterapi Kongresi, 1989 Istanbul, 11-14 Ekim, (sözlü bildiri), A: 40.
58. Soysal T., Ferhanoğlu B., Aydın Y. A., Ülkü B., Aktuğlu G., Akman N., Ulutin O. N. Kronik Lenfositik Lösemili Olgularımızın Değerlendirilmesi. II. Çinko Sempozyumu ve XX. Ulusal Hematoloji Kongresi, Ankara, 21- 25 Kasım 1988.
59. Ulutin,O.N., Ulutin-Balkuv,Ş., Erbengi,T., Yardımcı,T.,Çizmeci,G., Uğur,M.Ş., Özsoy,Y., Demirkoy,F., Ulutin,T., Uzman,F., Ferhanoğlu,B. Defibrotidin trombosit fonksiyonlarına etkisi. II.Çinko Sempozyumu ve XX.Ulusal Hematoloji Kongresi, Ankara, s.54, 21-25 Kasım l988.
60. Yardımcı,T., Uğur,M.Ş., Kılıç,M.Y., Ferhanoğlu,B., Ulutin,O.N. Aterosklerozlularda defibrotidin trombosit c-AMP düzeyine etkisi. II.Çinko Sempozyumu ve XX.Ulusal Hematoloji Kongresi, Ankara, s.55, 21-25 Kasım 1988.